Value Set ELGA_whoATC 2013‑01‑10

1.2.40.0.34.10.73

Gültigkeit

gültig ab 2013‑01‑10

Status

Definitiv

Versions-Label

Name

ELGA_whoATC

Anzeigename

ELGA_whoATC

Beschreibung

ELGA Valueset für ATC

Quell-Codesystem

2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification

Level/ Typ	Code	Anzeigename	Codesystem
0‑L	A	Alimentäres System und Stoffwechsel	WHO Anatomical Therapeutic Chemical classification
0‑L	A01	Stomatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	A01a	Stomatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA	Mittel zur Kariesprophylaxe	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA01	Natriumfluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA02	Natriummonofluorphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA03	Olaflur	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA04	Zinn(II)-fluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA51	Natriumfluorid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB	Antiinfektiva und Antiseptika zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB02	Wasserstoffperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB03	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB04	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB05	Polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB06	Domiphen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB07	Oxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB08	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB09	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB10	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB11	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB12	Hexetidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB13	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB14	Benzoxoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB15	Tibezoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB16	Mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB17	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB18	Clotrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB19	Natriumperborat	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB21	Chlortetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB22	Doxycyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB23	Minocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC	Corticosteroide zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC01	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC02	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC03	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC54	Prednisolon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD	Andere Mittel zur oralen Lokalbehandlung	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD01	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD02	Benzydamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD05	Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD06	Adrenalon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD07	Amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD11	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	A02	Mittel bei säure bedingten Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02A	Antacida	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA	Magnesium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA01	Magnesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA02	Magnesiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA03	Magnesiumperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA04	Magnesiumhydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA05	Magnesiumsilikat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB	Aluminium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB01	Aluminiumhydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB02	Algeldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB03	Aluminiumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB04	Dihydroxyalumiumnatriumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB05	Aluminiumacetoacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB06	Aloglutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB07	Aluminiumglycinat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC	Calcium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC01	Calciumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC02	Calciumsilikat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD	Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD01	Einfache Salzkombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD02	Magaldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD03	Almagat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD04	Hydrotalcit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD05	Almasilat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF	Antacida mit Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF01	Magaldrat und Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF02	Einfache Salzkombinationen und Karminativa	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AG	Antacida mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AH	Antacida mit Natriumbicarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AX	Antacida, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02B	Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA	Histamin-H2-Rezeptorantagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA01	Cimetidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA02	Ranitidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA03	Famotidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA04	Nizatidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA05	Niperotidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA06	Roxatidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA07	Ranitidinbismutcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA08	Lafutidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA51	Cimetidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA53	Famotidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB	Prostaglandine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB01	Misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB02	Enprostil	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC	Protonenpumpenhemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC01	Omeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC02	Pantoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC03	Lansoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC04	Rabeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC05	Esomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC06	Dexlansoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD	Kombinationen zur Eradikation von Helicobacter pylori	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD01	Omeprazol, Amoxicillin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD02	Lansoprazol, Tetracyclin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD03	Lansoprazol, Amoxicillin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD04	Pantoprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD05	Omeprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD06	Esomeprazol, Amoxicillin und Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD08	Bismutsubcitrat, Tetracyclin und Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX	Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX01	Carbenoxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX02	Sucralfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX03	Pirenzepin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX04	Methiosulfoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX05	Bismutsubcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX06	Proglumid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX07	Gefarnat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX08	Sulglicotid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX09	Acetoxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX10	Zolimidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX11	Troxipid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX12	Bismutsubnitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX13	Alginsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX51	Carbenoxolon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX71	Carbenoxolon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX77	Gefarnat, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A02X	Andere Mittel bei säure bedingten Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03	Mittel bei funktionellen gastrointestinalen Störungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03A	Mittel bei funktionellen Störungen des Darms	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA	Synthetische Anticholinergika, Ester mit tertiären Aminogruppen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA01	Oxyphencyclimin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA03	Camylofin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA04	Mebeverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA05	Trimebutin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA06	Rociverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA07	Dicycloverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA08	Dihexyverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA09	Difemerin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA30	Piperidolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB	Synthetische Anticholinergika, quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB01	Benzilon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB02	Glycopyrronium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB03	Oxyphenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB04	Penthienat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB05	Propanthelin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB06	Otiloniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB07	Methanthelinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB08	Tridihexethyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB09	Isopropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB10	Hexocyclium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB11	Poldin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB12	Mepenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB13	Bevonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB14	Pipenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB15	Diphemanil	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB16	(2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB17	Tiemoniumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB18	Prifiniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB19	Timepidiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB21	Fenpiverinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB53	Oxyphenonium, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC	Synthetische Spasmolytika, Amide mit tertiären Aminen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC02	Dimethylaminopropionylphenothiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC04	Nicofetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC05	Tiropramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD	Papaverin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD01	Papaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD02	Drotaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD30	Moxaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE	Auf Serotonin-Rezeptoren wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE01	Alosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE02	Tegaserod	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE03	Cilansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX	Andere Mittel bei funktionellen Störungen des Darms	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX01	Fenpipran	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX02	Diisopromin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX03	Chlorbenzoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX04	Pinaverium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX05	Fenoverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX06	Idanpramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX07	Proxazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX08	Alverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX09	Trepibuton	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX10	Isomethepten	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX11	Caroverin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX12	Phloroglucinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX13	Silikone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX30	Trimethyldiphenylpropylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX58	Alverin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03B	BELLADONNA UND DERIVATE, REIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA	Belladonna-Alkaloide, tertiäre Amine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA01	Atropin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA03	Hyoscyamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA04	Belladonna-Gesamtalkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB	Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB01	Butylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB02	Methylatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB03	Methylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB04	Fentonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB05	Cimetropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03C	Spasmolytika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA	Synthetische Anticholinergika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA01	Isopropamid und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA02	Clidinium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA03	Oxyphencyclimin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA04	Otiloniumbromid und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA05	Glycopyrronium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA06	Bevonium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA07	Ambutonium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA08	Diphemanil und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA30	Emepronium und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA34	Propanthelin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB	Belladonna und Derivate in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB01	Methylscopolamin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB02	Belladonna-Gesamtalkaloide und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB03	Atropin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB04	Methylhomatropin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB31	Hyoscyamin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CC	Andere Spasmolytika in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03D	Spasmolytika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA	Synthetische Anticholinergika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA01	Tropenzilon und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA02	Pitofenon und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA03	Bevonium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA04	Ciclonium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA05	Camylofin und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA06	Trospium und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA07	Tiemoniumiodid und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB	Belladonna und Derivate in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB04	Butylscopolamin und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DC	Andere Spasmolytika in Kombination mit Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03E	Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	A03EA	Spasmolytika, Psycholeptika und Analgetika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A03ED	Spasmolytika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	A03F	Prokinetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA	Prokinetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA01	Metoclopramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA02	Cisaprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA03	Domperidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA04	Bromoprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA05	Alizaprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA06	Cleboprid	WHO Anatomical Therapeutic Chemical classification
0‑L	A04	Antiemetika und Mittel gegen Übelkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	A04A	Antiemetika und Mittel gegen Übelkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA	Serotonin-5HT3-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA01	Ondansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA02	Granisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA03	Tropisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA04	Dolasetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA05	Palonosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD	Andere Antiemetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD01	Scopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD02	Ceriumoxalat	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD04	Chlorbutanol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD05	Metopimazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD10	Dronabinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD11	Nabilon	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD12	Aprepitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD51	Scopolamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD54	Chlorbutanol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05	Gallen- und Lebertherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05A	Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA	Gallensäure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA01	Chenodeoxycholsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA02	Ursodeoxycholsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB	Zubereitungen zur Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB01	N-(Hydroxymethyl)nicotinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX	Andere Mittel zur Gallentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX01	Piprozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX02	Hymecromon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX03	Cyclobutyrol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05B	Lebertherapie, Lipotrope Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA	Lebertherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA01	Argininglutamat	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA03	Silymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA04	Citiolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA05	Epomediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA06	Ornithinoxoglurat	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA07	Tidiacicarginin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05C	Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06	Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06A	Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA	Gleitmittel, Emollientia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA01	Dickflüssiges Paraffin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA02	Docusat-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA51	Dickflüssiges Paraffin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB	Kontaktlaxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB01	Oxyphenisatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB02	Bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB03	Dantron	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB04	Phenolphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB05	Rizinusöl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB06	Sennoside	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB07	Cascara	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB08	Natriumpicosulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB09	Bisoxatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB20	Kontaktlaxanzien in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB30	Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB52	Bisacodyl, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB53	Dantron, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB56	Sennoside, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB57	Cascara, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB58	Natriumpicosulfat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC	Quellmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC01	Ispaghula (Flohsamen)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC02	Ethulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC03	Sterculia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC05	Leinsamen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC06	Methylcellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC07	Triticum (Weizenkleie)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC08	Polycarbophil-Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC51	Ispaghula, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC53	Sterculia, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC55	Leinsamen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD	Osmotisch wirkende Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD01	Magnesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD02	Magnesiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD03	Magnesiumperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD04	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD10	Mineralsalze in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD11	Lactulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD12	Lactitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD13	Natriumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD14	Pentaerythrityl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD15	Macrogol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD16	Mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD17	Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD18	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD19	Magnesiumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD21	Natriumtartrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD61	Lactulose, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD65	Macrogol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG	Klysmen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG01	Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG02	Bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG03	Dantron, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG04	Glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG06	Öl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG07	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG10	Docusat-Natrium, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG11	Laurylsulfat, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH01	Methylnaltrexon bromid	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX	Andere Laxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX01	Glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX02	Kohlendioxid-freisetzende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A07	Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07A	Intestinale Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA01	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA02	Nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA03	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA04	Streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA05	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA06	Paromomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA07	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA08	Kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA09	Vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA10	Colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA11	Rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA12	Fidaxomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA51	Neomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA54	Streptomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB	Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB02	Phthalylsulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB03	Sulfaguanidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB04	Succinylsulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC	Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC01	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX	Andere intestinale Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX01	Broxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX02	Acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX03	Nifuroxazid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX04	Nifurzid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07B	Intestinale Adsorbenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA	Kohle-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA01	Medizinische Kohle	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA51	Medizinische Kohle, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BB	Bismut-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC	Andere intestinale Adsorbenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC01	Pektin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC02	Kaolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC03	Crospovidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC04	Attapulgit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC05	Diosmectit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC54	Attapulgit, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07C	Elektrolyte mit Kohlenhydraten	WHO Anatomical Therapeutic Chemical classification
0‑L	A07CA	Elektrolyte zur oralen Rehydrierung	WHO Anatomical Therapeutic Chemical classification
0‑L	A07D	Motilitätshemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA	Motilitätshemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA01	Diphenoxylat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA02	Opium	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA03	Loperamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA04	Difenoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA05	Loperamidoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA52	Morphin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA53	Loperamid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07E	Intestinale Antiphlogistika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA	Corticosteroide mit lokaler Wirkung	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA01	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA02	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA03	Prednison	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA04	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA05	Tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA06	Budesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA07	Beclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB	Antiallergika, exkl. Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB01	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC	Aminosalicylsäure und ähnliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC01	Sulfasalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC02	Mesalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC03	Olsalazin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC04	Balsalazid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07F	Mikrobielle Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA	Mikrobielle Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA01	Milchsäurebildner	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA02	Saccharomyces boulardii	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA51	Milchsäurebildner, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07X	Andere Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA	Andere Antidiarrhoika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA01	Albumintannat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA02	Ceratonia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA03	Calcium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA04	Racecadotril	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA51	Albumintannat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A08	Abmagerungsmittel, Exkl. Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A08A	Abmagerungsmittel, Exkl. Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA	Zentral wirkende Abmagerungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA01	Phentermin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA02	Fenfluramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA03	Amfepramon	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA04	Dexfenfluramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA05	Mazindol	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA06	Etilamfetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA07	Cathin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA08	Clobenzorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA09	Mefenorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA10	Sibutramin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA56	Ephedrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB	Peripher wirkende Abmagerungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB01	Orlistat	WHO Anatomical Therapeutic Chemical classification
0‑L	A09	Digestiva, Inkl. Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	A09A	Digestiva, Inkl. Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA	Enzym-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA01	Diastase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA02	Multienzyme (Lipase, Protease etc.)	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA03	Pepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA04	Tilactase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB	Säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB01	Glutaminsäurehydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB02	Betainhydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB03	Salzsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB04	Zitronensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC	Enzym- und Säure-haltige Zubereitungen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC01	Pepsin- und Säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC02	Multienzyme und säure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10	Antidiabetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10A	Insuline Und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AA	Insulins	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB	Insuline und Analoga zur Injektion, schnell wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB05	Insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB06	Insulin glulisin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC	Insuline und Analoga zur Injektion, intermediär wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD	Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD05	Insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE	Insuline und Analoga zur Injektion, lang wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE02	Insulin (Rind)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE04	Insulin glargin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE05	Insulin detemir	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF	Insuline und Analoga zur Inhalation	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF01	Insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10B	Antidiabetika, Exkl. Insuline	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA	Biguanide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA01	Phenformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA02	Metformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA03	Buformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB	Sulfonylharnstoff-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB01	Glibenclamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB02	Chlorpropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB03	Tolbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB04	Glibornurid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB05	Tolazamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB06	Carbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB07	Glipizid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB08	Gliquidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB09	Gliclazid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB10	Metahexamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB11	Glisoxepid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB12	Glimepirid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB31	Acetohexamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC	Sulfonamide (heterozyklisch)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC01	Glymidin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD	Kombinationen mit oralen Antidiabetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD01	Phenformin und Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD02	Metformin und Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD03	Metformin und Rosiglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD04	Glimepirid und Rosiglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD05	Metformin und Pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD06	Glimepirid und Pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD07	Metformin und Sitagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD08	Metformin und Vildagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD13	Metformin und Alogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF	Alpha-Glukosidasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF01	Acarbose	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF02	Miglitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF03	Voglibose	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG	Thiazolidindione	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG01	Troglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG02	Rosiglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG03	Pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH01	Sitagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH02	Vildagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH04	Alogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX	Andere Antidiabetika, exkl. Insuline	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX01	Guar-Mehl	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX02	Repaglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX03	Nateglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX04	Exenatid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10X	Andere Antidiabetika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA	Aldosereduktasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA01	Tolrestat	WHO Anatomical Therapeutic Chemical classification
0‑L	A11	Vitamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A11A	Multivitamine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA	Multivitamine mit Mineralstoffen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA01	Multivitamine und Eisen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA02	Multivitamine und Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA03	Multivitamine und andere Mineralstoffe, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA04	Multivitamine und Spurenelemente	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AB	Multivitamine, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11B	Multivitamine, Rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11BA	Multivitamine, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11C	Vitamin A und D, inkl. deren Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA	Vitamin A, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA01	Retinol (Vitamin A)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA02	Betacaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CB	Vitamin A und D in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC	Vitamin D und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC01	Ergocalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC02	Dihydrotachysterol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC03	Alfacalcidol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC04	Calcitriol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC05	Colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC06	Calcifediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC07	Paricalcitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11D	Vitamin-B1, rein und in Kombination mit Vitamin-B6 und Vitamin-B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA	Vitamin-B1, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA01	Thiamin (Vitamin-B1)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA02	Sulbutiamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA03	Benfotiamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DB	Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11E	Vitamin-B-Komplex, inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EA	Vitamin-B-Komplex, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EB	Vitamin-B-Komplex mit Vitamin C	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EC	Vitamin-B-Komplex mit Mineralstoffen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11ED	Vitamin-B-Komplex mit anabolen Steroiden	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EX	Vitamin-B-Komplex, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11G	Ascorbinsäure (Vitamin C), inkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA	Ascorbinsäure (Vitamin C), rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA01	Ascorbinsäure (Vitamin C)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB	Ascorbinsäure (Vitamin C), Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB01	Ascorbinsäure (Vitamin C) und Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A11H	Andere Vitaminpräparate, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA	Andere Vitaminpräparate, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA01	Nicotinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA02	Pyridoxin (Vitamin-B6)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA03	Tocopherol (Vitamin E)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA04	Riboflavin (Vitamin-B2)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA05	Biotin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA06	Pyridoxalphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA07	Inositol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA30	Dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA31	Calciumpantothenat	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA32	Pantethin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11J	Andere Vitaminpräparate, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JA	Kombinationen von Vitaminen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JB	Vitamine mit Mineralstoffen	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JC	Vitamine, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12	Mineralstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	A12A	Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA	Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA01	Calciumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA02	Calciumglubionat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA03	Calciumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA04	Calciumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA05	Calciumlactat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA06	Calciumlactogluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA07	Calciumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA08	Calciumglycerylphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA09	Calciumcitratlysin-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA10	Calciumglucoheptonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA11	Calciumpangamat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA12	Calciumacetat, wasserfrei	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA20	Calcium (verschiedene Salze in Kombination)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA30	Calciumlaevulat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AX	Calcium, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AX01	Calciumcarbonat und Colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A12B	Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA	Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA01	Kaliumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA02	Kaliumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA03	Kaliumhydrogentartrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA04	Kaliumhydrogencarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA05	Kaliumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA51	Kaliumchlorid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12C	Andere Mineralstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA	Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA01	Natriumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA02	Natriumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB	Zink	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB01	Zinksulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB02	Zinkgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB03	Zinkprotein-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC	Magnesium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC01	Magnesiumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC02	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC03	Magnesiumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC04	Magnesiumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC05	Magnesiumaspartat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC06	Magnesiumlactat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC07	Magnesiumlevulinat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC08	Magnesiumpidolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC09	Magnesiumorotat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC10	Magnesiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC11	Magnesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC30	Magnesium (verschiedene Salze in Kombination)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD	Fluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD01	Natriumfluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD02	Natriummonofluorphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD51	Natriumfluorid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE	Selen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE01	Natriumselenat	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE02	Natriumselenit	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CX	Andere Mineralstoff-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	A13	Tonika	WHO Anatomical Therapeutic Chemical classification
0‑L	A13A	Tonika	WHO Anatomical Therapeutic Chemical classification
0‑L	A14	Anabolika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	A14A	Anabole Steroide	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA	Androstan-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA01	Androstanolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA02	Stanozolol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA03	Metandienon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA04	Metenolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA05	Oxymetholon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA06	Quinbolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA07	Prasteron	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA08	Oxandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA09	Norethandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB	Estren-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB01	Nandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB02	Ethylestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB03	Oxaboloncipionat	WHO Anatomical Therapeutic Chemical classification
0‑L	A14B	Andere Anabolika	WHO Anatomical Therapeutic Chemical classification
0‑L	A15	Appetit stimulierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16	Andere Mittel für das alimentäre System und den Stoffwechsel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16A	Andere Mittel für das alimentäre System und den Stoffwechsel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA	Aminosäuren und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA01	Levocarnitin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA02	Ademetionin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA03	Glutamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA04	Mercaptamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA05	Carglumsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA06	Betain	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB01	Alglucerase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB02	Imiglucerase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB03	Agalsidase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB04	Agalsidase beta	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB05	Laronidase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB06	Sacrosidase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB07	Alglucosidase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB08	Galsulfase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB09	Idursulfase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB10	Velaglucerase Alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX	Sonstige Mittel für das alimentäre System und den Stoffwechsel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX01	Alpha-Liponsäure (Thioctsäure)	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX02	Anetholtrithion	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX03	Natriumphenylbutyrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX04	Nitisinon	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX05	Zinkacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX06	Miglustat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX07	Sapropterin	WHO Anatomical Therapeutic Chemical classification
0‑L	B	Blut und Blut bildende Organe	WHO Anatomical Therapeutic Chemical classification
0‑L	B01	Antithrombotische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01A	Antithrombotische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA	Vitamin-K-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA01	Dicoumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA02	Phenindion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA03	Warfarin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA04	Phenprocoumon	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA07	Acenocoumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA08	Ethylbiscoumacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA09	Clorindion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA10	Diphenadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA11	Tioclomarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB	Heparingruppe	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB01	Heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB02	Antithrombin III	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB04	Dalteparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB05	Enoxaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB06	Nadroparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB07	Parnaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB08	Reviparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB09	Danaparoid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB10	Tinzaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB11	Sulodexid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB12	Bemiparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB51	Heparin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC	Thrombozytenaggregationshemmer, exkl. Heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC01	Ditazol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC02	Cloricromen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC03	Picotamid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC04	Clopidogrel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC05	Ticlopidin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC06	Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC07	Dipyridamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC08	Carbasalatcalcium	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC09	Epoprostenol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC10	Indobufen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC11	Iloprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC13	Abciximab	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC15	Aloxiprin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC16	Eptifibatid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC17	Tirofiban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC18	Triflusal	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC19	Beraprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC21	Treprostinil	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC56	Acetylsalicylsäure und Esomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD01	Streptokinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD02	Alteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD03	Anistreplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD04	Urokinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD05	Fibrinolysin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD06	Brinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD07	Reteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD08	Saruplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD09	Ancrod	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD10	Drotrecogin alfa (aktiviert)	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD11	Tenecteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD12	Protein C	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE	Direkte Thrombininhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE01	Desirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE02	Lepirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE03	Argatroban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE04	Melagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE05	Ximelagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE06	Bivalirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE07	Dabigatran etexilat	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX	Andere antithrombotische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX01	Defibrotid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX04	Chondroitinsulfat B	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX05	Fondaparinux	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX06	Rivaroxaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B02	Antihämorrhagika	WHO Anatomical Therapeutic Chemical classification
0‑L	B02A	Antifibrinolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA	Aminosäuren	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA01	Aminocapronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA02	Tranexamsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA03	Aminomethylbenzoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB	Proteinasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB01	Aprotinin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB02	Alfa1-Antitrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB03	C1-Inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB04	Camostat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02B	Vitamin K und andere Hämostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA	Vitamin K	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA01	Phytomenadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA02	Menadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB	Fibrinogene	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB01	Fibrinogen, human	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC	Lokale Hämostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC01	Absorbierbarer Gelatineschwamm	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC02	Oxidierte Zellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC03	Tetragalacturonsäurehydroxymethylester	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC05	Adrenalon	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC06	Thrombin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC07	Kollagen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC08	Calciumalginat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC09	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC10	Fibrinogen, human	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD	Blutgerinnungsfaktoren	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD01	Gerinnungsfaktoren IX, II, VII und X in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD02	Gerinnungsfaktor VIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD03	Faktor-VIII-Inhibitor bypass Aktivität	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD04	Gerinnungsfaktor IX	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD05	Gerinnungsfaktor VII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD06	Von-Willebrand-Faktor und Gerinnungsfaktor VIII in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD07	Gerinnungsfaktor XIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD08	Eptacog alfa (aktiviert)	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD09	Nonacog alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD10	von-Willebrand-Faktor	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD30	Thrombin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX	Andere systemische Hämostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX01	Etamsylat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX02	Carbazochrom	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX03	Batroxobin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX04	Romiplostim	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX05	Eltrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B03	Antianämika	WHO Anatomical Therapeutic Chemical classification
0‑L	B03A	Eisen-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA	Eisen zweiwertig, orale Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA01	Eisen(II)-Glycinsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA02	Eisen(II)fumarat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA03	Eisen(II)gluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA04	Eisen(II)carbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA05	Eisen(II)chlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA06	Eisen(II)succinat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA07	Eisen(II)sulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA08	Eisen(II)tartrat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA09	Eisen(II)aspartat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA10	Eisen(II)ascorbat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA11	Eisen(II)iodat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB	Eisen dreiwertig, orale Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB01	Eisen(III)-Natrium-citrat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB02	Eisen(III)oxid-Saccharose-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB03	Natriumferedetat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB04	Eisen(III)hydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB05	Dextriferron	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB06	Eisen(III)citrat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB07	Chondroitinsulfat-Eisen(III)-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB08	Eisen(III)acetyltransferrin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB09	Eisen(III)proteinsuccinylat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC	Eisen dreiwertig, parenterale Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC01	Dextriferron	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC02	Eisen(III)oxid-Saccharose-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC03	Eisen(III)sorbit-Zitronensäure-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC05	Eisen(III)sorbit-Gluconsäure-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC06	Eisen(III)oxid-Dextran-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC07	Eisen(III)-Natrium-Gluconat-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD	Eisen in Kombination mit Folsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD01	Eisen-Aminosäure-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD02	Eisen(II)fumarat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD03	Eisen(II)sulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD04	Dextriferron	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE	Eisen in anderen Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE01	Eisen, Vitamin-B12 und Folsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE02	Eisen, Multivitamine und Folsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE03	Eisen und Multivitamine	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE04	Eisen, Multivitamine und Mineralstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE10	Verschiedene Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03B	Vitamin-B12 und Folsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA	Vitamin-B12 (Cyanocobalamin und Analoga)	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA01	Cyanocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA02	Cyanocobalamin-Tannin-Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA03	Hydroxocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA04	Cobamamid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA05	Mecobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA51	Cyanocobalamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA53	Hydroxocobalamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB	Folsäure und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB01	Folsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB51	Folsäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B03X	Andere Antianämika	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA	Andere Antianämika	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA01	Erythropoietin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA02	Darbepoetin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA03	Methoxy-Polyethylenglycol-Epoetin beta	WHO Anatomical Therapeutic Chemical classification
0‑L	B05	Blutersatzmittel und Perfusionslösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05A	Blut und verwandte Produkte	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA	Blutersatzmittel und Plasmaproteinfraktionen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA01	Albumin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA02	Andere Plasmaproteinfraktionen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA03	Fluorocarbon-Blutersatzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA05	Dextran	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA06	Gelatine-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA07	Hydroxyethylstärke	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA08	Hämoglobin crosfumaril	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA09	Haemoglobin raffimer	WHO Anatomical Therapeutic Chemical classification
0‑L	B05B	I.V.-Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA	Lösungen zur parenteralen Ernährung	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA01	Aminosäuren	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA02	Fett-Emulsionen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA03	Kohlenhydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA04	Proteinhydrolysate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB	Lösungen mit Wirkung auf den Elektrolythaushalt	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB01	Elektrolyte	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB02	Elektrolyte mit Kohlenhydraten	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB03	Trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC	Osmodiuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC01	Mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC02	Harnstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	B05C	Spüllösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA01	Cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA02	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA03	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA04	Sulfamethizol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA05	Taurolidin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA06	Mandelsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA07	Noxytiolin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA08	Ethacridinlactat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA09	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB	Salzlösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB01	Natriumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB02	Natriumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB03	Magnesiumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB04	Natriumbicarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX	Andere Spüllösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX01	Glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX02	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX03	Glycin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX04	Mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05D	LÖSUNGEN ZUR PERITONEALDIALYSE	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DA	Isotone Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DB	Hypertone Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05X	ADDITIVA ZU I.V.-LÖSUNGEN	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA	Elektrolytlösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA01	Kaliumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA02	Natriumbicarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA03	Natriumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA04	Ammoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA05	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA06	Kaliumphosphat, inkl. Kombinationen mit anderen Kaliumsalzen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA07	Calciumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA08	Natriumacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA09	Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA10	Magnesiumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA11	Magnesiumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA12	Zinkchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA13	Salzsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA14	Dinatrium-1-glycerinphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA15	Kaliumlactat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA16	Kardioplege Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA30	Kombinationen von Elektrolyten	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA31	Elektrolyte in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB	Aminosäuren	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB01	Argininhydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB02	Alanylglutamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB03	Lysin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XC	Vitamine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX	Andere Additiva zu i.v.-Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX02	Trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05Z	Hämodialysekonzentrate und Hämofiltrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZA	Hämodialysekonzentrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZB	Hämofiltrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B06	Andere Hämatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	B06A	Andere Hämatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA02	Fibrinolysin und Desoxyribonuclease	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA03	Hyaluronidase	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA04	Chymotrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA07	Trypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA10	Desoxyribonuclease	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA11	Bromelaine	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA55	Streptokinase, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB	Andere Hämprodukte	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB01	Hematin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC01	C1-Inhibitor, plasma derived	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC04	Conestat alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	C	Kardiovaskuläres System	WHO Anatomical Therapeutic Chemical classification
0‑L	C01	Herztherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	C01A	Herzglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA	Digitalisglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA01	Acetyldigitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA02	Acetyldigoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA03	Digitalisblätter	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA04	Digitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA05	Digoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA06	Lanatosid C	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA07	Deslanosid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA08	Metildigoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA09	Gitoformat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA52	Acetyldigoxin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB	Scillaglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB01	Proscillaridin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB51	Proscillaridin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC	Strophanthusglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC01	g-Strophanthin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC03	Cymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX	Andere Herzglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX02	Peruvosid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01B	Antiarrhythmika, Klasse I und III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA	Antiarrhythmika, Klasse Ia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA01	Chinidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA02	Procainamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA03	Disopyramid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA04	Spartein	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA05	Ajmalin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA08	Prajmalin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA12	Lorajmin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA51	Chinidin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA71	Chinidin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB	Antiarrhythmika, Klasse Ib	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB01	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB02	Mexiletin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB03	Tocainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB04	Aprindin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC	Antiarrhythmika, Klasse Ic	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC03	Propafenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC04	Flecainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC07	Lorcainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC08	Encainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD	Antiarrhythmika, Klasse III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD01	Amiodaron	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD02	Bretyliumtosilat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD03	Bunaftin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD04	Dofetilid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD05	Ibutilid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG	Andere Klasse-I-Antiarrhythmika	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG01	Moracizin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG07	Cibenzolin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG11	Vernakalant	WHO Anatomical Therapeutic Chemical classification
0‑L	C01C	Kardiostimulanzien, Exkl. Herzglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA	Adrenerge und dopaminerge Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA01	Etilefrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA02	Isoprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA03	Norepinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA04	Dopamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA05	Norfenefrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA06	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA07	Dobutamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA08	Oxedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA09	Metaraminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA10	Methoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA11	Mephentermin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA12	Dimetofrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA13	Prenalterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA14	Dopexamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA15	Gepefrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA16	Ibopamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA17	Midodrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA18	Octopamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA19	Fenoldopam	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA21	Cafedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA22	Arbutamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA23	Theodrenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA24	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA26	Ephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA51	Etilefrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE	Phosphodiesterasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE01	Amrinon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE02	Milrinon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE03	Enoximon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE04	Bucladesin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX	Andere Kardiostimulanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX06	Angiotensinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX07	Xamoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX08	Levosimendan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01D	Bei Herzerkrankungen Eingesetzte Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA	Organische Nitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA02	Glyceroltrinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA04	Methylpropylpropanedioldinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA05	Pentaerythrityltetranitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA07	Propatylnitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA08	Isosorbiddinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA09	Trolnitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA13	Erythrityltetranitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA14	Isosorbidmononitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA20	Organische Nitrate in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA38	Tenitramin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA52	Glyceroltrinitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA54	Methylpropylpropanedioldinitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA55	Pentaerythrityltetranitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA57	Propatylnitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA58	Isosorbiddinitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA59	Trolnitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA63	Erythrityltetranitrat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA70	Organische Nitrate in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB	Chinolon-Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB01	Flosequinan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX	Andere bei Herzerkrankungen eingesetzte Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX01	Itramintosilat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX02	Prenylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX03	Oxyfedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX04	Benziodaron	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX05	Carbocromen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX06	Hexobendin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX07	Etafenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX08	Heptaminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX09	Imolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX10	Dilazep	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX11	Trapidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX12	Molsidomin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX13	Efloxat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX14	Cinepazet	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX15	Cloridarol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX16	Nicorandil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX18	Linsidomin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX19	Nesiritid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX51	Itramintosilat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX52	Prenylamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX53	Oxyfedrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX54	Benziodaron, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01E	Andere Herzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA	Prostaglandine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA01	Alprostadil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB	Andere Herzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB02	Campher	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB03	Indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB04	Crataegus-Glykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB05	Creatinolfosfat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB06	Fosfocreatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB07	Fructose-1,6-diphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB09	Ubidecarenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB10	Adenosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB11	Tiracizin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB12	Tedisamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB13	Acadesin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB15	Trimetazidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB16	Ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB17	Ivabradin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB18	Ranolazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB21	Regadenoson	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EX	Andere Herzmittel, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02	Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02A	Antiadrenerge Mittel, zentral wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA	Rauwolfia-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA01	Rescinnamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA02	Reserpin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA03	Kombinationen von Rauwolfia-Alkaloiden	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA04	Rauwolfia-Alkaloide, ganze Wurzel	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA05	Deserpidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA06	Methoserpidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA07	Bietaserpin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA52	Reserpin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA53	Kombinationen von Rauwolfia-Alkaloiden, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA57	Bietaserpin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB	Methyldopa	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB01	Methyldopa (linksdrehend)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB02	Methyldopa (racemisch)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC	Imidazolin-Rezeptoragonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC01	Clonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC02	Guanfacin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC04	Tolonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC05	Moxonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC06	Rilmenidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02B	Antiadrenerge Mittel, Ganglienblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA	Sulfonium-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA01	Trimetaphan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB	Sekundäre und tertiäre Amine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB01	Mecamylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BC	Bisquartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02C	Antiadrenerge Mittel, peripher wirkend	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA	Alpha-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA01	Prazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA02	Indoramin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA03	Trimazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA04	Doxazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA06	Urapidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC	Guanidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC01	Betanidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC02	Guanethidin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC03	Guanoxan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC04	Debrisoquin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC05	Guanoclor	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC06	Guanazodin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC07	Guanoxabenz	WHO Anatomical Therapeutic Chemical classification
0‑L	C02D	mittel mit Wirkung auf die arterielle Gefässmuskulatur	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA	Thiazid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA01	Diazoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB	Hydrazinophthalazin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB01	Dihydralazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB02	Hydralazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB03	Endralazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB04	Cadralazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC	Pyrimidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC01	Minoxidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD	Nitroferrocyanid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD01	Nitroprussid	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DF	Non-thiazide sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG	Guanidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG01	Pinacidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02K	Andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA	Alkaloide, exkl. Rauwolfia	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA01	Veratrum	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB	Tyrosinhydroxylasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB01	Metirosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC	MAO-Hemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC01	Pargylin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD	Serotonin-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD01	Ketanserin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX	Andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX01	Bosentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX02	Ambrisentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX03	Sitaxentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02L	Antihypertonika und Diuretika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA	Rauwolfia-Alkaloide und Diuretika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA01	Reserpin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA02	Rescinnamin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA03	Deserpidin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA04	Methoserpidin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA07	Bietaserpin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA08	Rauwolfia-Alkaloide, ganze Wurzel und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA09	Syrosingopin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA50	Kombinationen von Rauwolfia-Alkaloiden und Diuretika inkl. andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA51	Reserpin und Diuretika, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA52	Rescinnamin und Diuretika, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA71	Reserpin und Diuretika, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB	Methyldopa und Diuretika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB01	Methyldopa (linksdrehend) und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC	Imidazolin-Rezeptoragonisten in Kombination mit Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC01	Clonidin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC05	Moxonidin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC51	Clonidin und Diuretika, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE	Alpha-Adrenorezeptor-Antagonisten und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE01	Prazosin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF	Guanidin-Derivate und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF01	Guanethidin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG	Hydrazinophthalazin-Derivate und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG01	Dihydralazin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG02	Hydralazin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG03	Picodralazin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG51	Dihydralazin und Diuretika, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG73	Picodralazin und Diuretika, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LI	Calcium channel blockers and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK	Alkaloide, exkl. Rauwolfia, in Kombination mit Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK01	Veratrum und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL	MAO-Hemmer und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL01	Pargylin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LN	Serotonin-Antagonisten und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX	Andere Antihypertonika und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX01	Pinacidil und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C02N	Kombinationen von antihypertensiven Wirkstoffen aus ATC-Gruppe C02	WHO Anatomical Therapeutic Chemical classification
0‑L	C03	Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03A	Low-Ceiling-Diuretika, Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA	Thiazide, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA01	Bendroflumethiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA02	Hydroflumethiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA03	Hydrochlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA04	Chlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA05	Polythiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA06	Trichlormethiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA07	Cyclopenthiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA08	Methylclothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA09	Cyclothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA13	Mebutizid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB	Thiazide und Kalium in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB01	Bendroflumethiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB02	Hydroflumethiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB03	Hydrochlorothiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB04	Chlorothiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB05	Polythiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB06	Trichlormethiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB07	Cyclopenthiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB08	Methylclothiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB09	Cyclothiazid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH	Thiazide, Kombinationen mit Psycholeptika und/oder Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH01	Chlorothiazid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH02	Hydroflumethiazid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX	Thiazide, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX01	Hydrochlorothiazid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C03B	Low-Ceiling-Diuretika, exkl. Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA	Sulfonamide, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA02	Quinethazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA03	Clopamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA04	Chlortalidon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA05	Mefrusid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA07	Clofenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA08	Metolazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA09	Meticran	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA10	Xipamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA11	Indapamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA12	Clorexolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA13	Fenquizon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA82	Clorexolon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB	Sulfonamide und Kalium in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB02	Quinethazon und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB03	Clopamid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB04	Chlortalidon und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB05	Mefrusid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB07	Clofenamid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC	Quecksilber-haltige Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC01	Mersalyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD	Xanthin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD01	Theobromin	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BK	Sulfonamide, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX	Andere Low-ceiling-Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX03	Cicletanin	WHO Anatomical Therapeutic Chemical classification
0‑L	C03C	High-Ceiling-Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA	Sulfonamide, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA01	Furosemid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA02	Bumetanid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA03	Piretanid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA04	Torasemid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB	Sulfonamide und Kalium in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB01	Furosemid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB02	Bumetanid und Kalium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC	Aryloxyessigsäure-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC01	Etacrynsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC02	Tienilinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD	Pyrazolon-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD01	Muzolimin	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX	Andere High-ceiling-Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX01	Etozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	C03D	Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA	Aldosteron-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA01	Spironolacton	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA02	Kaliumcanrenoat	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA03	Canrenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA04	Eplerenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB	Andere Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB01	Amilorid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB02	Triamteren	WHO Anatomical Therapeutic Chemical classification
0‑L	C03E	Diuretika und Kalium sparende Mittel in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA	Low-ceiling-Diuretika und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA01	Hydrochlorothiazid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA02	Trichlormethiazid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA03	Epitizid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA04	Altizid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA05	Mebutizid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA06	Chlortalidon und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA07	Cyclopenthiazid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA12	Metolazon und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA13	Bendroflumethiazid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA14	Butizid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB	High-ceiling-Diuretika und Kalium sparende Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB01	Furosemid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB02	Bumetanid und Kalium sparende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C04	Periphere Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C04A	Periphere Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA	2-Amino-1-phenylethanol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA01	Isoxsuprin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA02	Buphenin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA31	Bamethan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB	Imidazolin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB01	Phentolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB02	Tolazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC	Nicotinsäure und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC01	Nicotinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC02	Nicotinylalkohol (Pyridylcarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC03	Inositolnicotinat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC07	Ciclonicat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD	Purin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD01	Pentifyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD02	Xantinolnicotinat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD03	Pentoxifyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD04	Etofyllinnicotinat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE	Mutterkorn-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE01	Ergoloidmesylat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE02	Nicergolin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE04	Dihydroergocristin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE51	Ergoloidmesylat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE54	Dihydroergocristin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF01	Kallidinogenase	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX	Andere periphere Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX01	Cyclandelat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX02	Phenoxybenzamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX07	Vincamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX10	Moxisylyt	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX11	Bencyclan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX17	Vinburnin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX19	Suloctidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX20	Buflomedil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX21	Naftidrofuryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX23	Butalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX24	Visnadin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX26	Cetiedil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX27	Cinepazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX28	Ifenprodil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX30	Azapetin	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX32	Fasudil	WHO Anatomical Therapeutic Chemical classification
0‑L	C05	Vasoprotektoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C05A	Hämorrhoidenmittel zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA	Corticosteroid-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA01	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA04	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA05	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA06	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA08	Fluocortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA09	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA10	Fluocinolonacetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA11	Fluocinonid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AB	Antibiotika-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD	Lokalanästhetika-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD01	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD02	Tetracain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD03	Benzocain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD04	Cinchocain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD05	Procain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD06	Oxetacain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD07	Pramocain	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE01	Glyceroltrinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX	Andere Hämorrhoidenmittel zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX01	Aluminium-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX02	Bismutpräparate, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX03	Andere Hämorrhoidenmittel, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX04	Zinkpräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX05	Tribenosid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05B	Antivarikosa	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA	Heparine oder Heparinoide zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA01	Heparinoide	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA02	Natriumapolat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA03	Heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA04	Natriumpentosanpolysulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA51	Heparinoid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA53	Heparin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB	Sklerosierende Mittel zur lokalen Injektion	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB01	Monoethanolaminoleat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB02	Polidocanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB03	Invertzucker	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB04	Natriumtetradecylsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB05	Phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB56	Glucose, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX	Andere sklerosierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX01	Calciumdobesilat	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX51	Calciumdobesilat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05C	Kapillarstabilisierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA	Bioflavonoide	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA01	Rutoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA02	Monoxerutin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA03	Diosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA04	Troxerutin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA05	Hidrosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA51	Rutosid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA53	Diosmin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA54	Troxerutin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CP02	Weinlaubblätter	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX	Andere kapillarstabilisierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX01	Tribenosid	WHO Anatomical Therapeutic Chemical classification
0‑L	C07	Beta-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C07A	Beta-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA01	Alprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA02	Oxprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA03	Pindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA05	Propranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA06	Timolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA07	Sotalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA12	Nadolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA14	Mepindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA15	Carteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA16	Tertatolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA17	Bopindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA19	Bupranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA23	Penbutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA27	Cloranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA57	Sotalol, Kombinationspackungen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB	Beta-Adrenorezeptor-Antagonisten, selektiv	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB01	Practolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB02	Metoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB03	Atenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB04	Acebutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB05	Betaxolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB06	Bevantolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB07	Bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB08	Celiprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB09	Esmolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB10	Epanolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB11	S-Atenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB12	Nebivolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB13	Talinolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB52	Metoprolol, Kombinationspackungen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB57	Bisoprolol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG	Alpha- und Beta-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG01	Labetalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG02	Carvedilol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07B	Beta-Adrenorezeptor-Antagonisten und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA02	Oxprenolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA05	Propranolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA06	Timolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA07	Sotalol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA12	Nadolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA68	Metipranolol und Thiazide, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB	Beta-Adrenorezeptor-Antagonisten, selektiv, und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB02	Metoprolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB03	Atenolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB04	Acebutolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB06	Bevantolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB07	Bisoprolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB12	Nebivolol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB52	Metoprolol und Thiazide, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG	Alpha- und Beta-Adrenorezeptor-Antagonisten und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG01	Labetalol und Thiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C07C	Beta-Adrenorezeptor-Antagonisten und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA02	Oxprenolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA03	Pindolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA17	Bopindolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA23	Penbutolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB	Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB02	Metoprolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB03	Atenolol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB53	Atenolol und andere Diuretika, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG	Alpha- und Beta-Adrenorezeptor-Antagonisten und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG01	Labetalol und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07D	Beta-Adrenorezeptor-Antagonisten, Thiazide und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv, Thiazide und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA06	Timolol, Thiazide und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB	Beta-Adrenorezeptor-Antagonisten, selektiv, Thiazide und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB01	Atenolol, Thiazide und andere Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07E	Beta-Adrenorezeptor-Antagonisten und Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EB	Beta-Adrenorezeptor-Antagonisten, selektiv, und Vasodilatatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C07F	Beta-Adrenorezeptor-Antagonisten und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FA	Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FA05	Propranolol und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB	Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB02	Metoprolol und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB03	Atenolol und andere Antihypertonika	WHO Anatomical Therapeutic Chemical classification
0‑L	C08	Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C08C	Selektive Calciumkanalblocker mit vorwiegender Gefässwirkung	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA	Dihydropyridin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA01	Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA02	Felodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA03	Isradipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA04	Nicardipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA05	Nifedipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA06	Nimodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA07	Nisoldipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA08	Nitrendipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA09	Lacidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA10	Nilvadipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA11	Manidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA12	Barnidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA13	Lercanidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA14	Cilnidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA15	Benidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA16	Clevidipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA55	Nifedipin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX	Andere selektive Calciumkanalblocker mit vorwiegender Gefässwirkung	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX01	Mibefradil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08D	Selektive Calciumkanalblocker mit direkter Herzwirkung	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA	Phenylalkylamin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA01	Verapamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA02	Gallopamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA51	Verapamil, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB	Benzothiazepin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB01	Diltiazem	WHO Anatomical Therapeutic Chemical classification
0‑L	C08E	Nichtselektive Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA	Phenylalkylamin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA01	Fendilin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA02	Bepridil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX	Andere nichtselektive Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX01	Lidoflazin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX02	Perhexilin	WHO Anatomical Therapeutic Chemical classification
0‑L	C08G	Calciumkanalblocker und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA	Calciumkanalblocker und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA01	Nifedipin und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09	Mittel mit Wirkung auf das Renin-Angiotensin-System	WHO Anatomical Therapeutic Chemical classification
0‑L	C09A	ACE-Hemmer, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA	ACE-Hemmer, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA01	Captopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA02	Enalapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA03	Lisinopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA04	Perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA05	Ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA06	Quinapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA07	Benazepril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA08	Cilazapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA09	Fosinopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA10	Trandolapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA11	Spirapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA12	Delapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA13	Moexipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA14	Temocapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA15	Zofenopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA16	Imidapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09B	ACE-Hemmer, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA	ACE-Hemmer und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA01	Captopril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA02	Enalapril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA03	Lisinopril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA04	Perindopril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA05	Ramipril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA06	Quinapril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA07	Benazepril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA08	Cilazapril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA09	Fosinopril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA12	Delapril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA13	Moexipril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA15	Zofenopril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB	ACE-Hemmer und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB02	Enalapril und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB03	Lisinopril und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB04	Perindopril und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB05	Ramipril und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB07	Ramipril und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB10	Trandolapril und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB12	Delapril und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09C	Angiotensin-Ii-Antagonisten, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA	Angiotensin-II-Antagonisten, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA01	Losartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA02	Eprosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA03	Valsartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA04	Irbesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA05	Tasosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA06	Candesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA07	Telmisartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA08	Olmesartan medoxomil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09D	Angiotensin-II-Antagonisten, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA	Angiotensin-II-Antagonisten und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA01	Losartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA02	Eprosartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA03	Valsartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA04	Irbesartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA06	Candesartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA07	Telmisartan und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA08	Olmesartan medoxomil und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB	Angiotensin-II-Antagonisten und Calciumkanalblocker	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB01	Valsartan und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB02	Olmesartanmedoxomil und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB04	Telmisartan/Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX01	Valsartan, Amlodipin und Hydrochlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX03	Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C09X	Andere Mittel mit Wirkung auf das Renin-Angiotensin-System	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA	Renin-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA01	Remikiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA02	Aliskiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA52	Aliskiren und Hydrochlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA53	Aliskiren und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA54	Aliskiren, Amlodipin und Hydrochlorothiazid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10	Mittel, die den Lipidstoffwechsel beeinflussen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10A	Mittel, die den Lipidstoffwechsel beeinflussen, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA	HMG-CoA-Reduktasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA01	Simvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA02	Lovastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA03	Pravastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA04	Fluvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA05	Atorvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA06	Cerivastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA07	Rosuvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA08	Pitavastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB	Fibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB01	Clofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB02	Bezafibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB03	Aluminiumclofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB04	Gemfibrozil	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB05	Fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB06	Simfibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB07	Ronifibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB08	Ciprofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB09	Etofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB10	Clofibrid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC	Gallensäure bindende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC01	Colestyramin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC02	Colestipol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC03	Colextran	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC04	Colesevelam	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD	Nicotinsäure und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD01	Niceritrol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD02	Nicotinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD03	Nicofuranose	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD04	Aluminiumnicotinat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD05	Nicotinylalkohol (Pyridylcarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD06	Acipimox	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD52	Nicotinsäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX	Andere Mittel, die den Lipidstoffwechsel beeinflussen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX01	Dextrothyroxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX02	Probucol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX03	Tiadenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX04	Benfluorex	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX05	Meglutol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX06	Omega-3-triglyceride	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX07	Magnesiumpyridoxal-5-phosphatglutamat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX08	Policosanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX09	Ezetimib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10B	Mittel, die den Lipidstoffwechsel beeinflussen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA	HMG-CoA-Reduktasehemmer in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA01	Lovastatin und Nicotinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA02	Simvastatin und Ezetimib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA05	Atorvastatin und Ezetimib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX	HMG-CoA-Reduktasehemmer, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX01	Simvastatin und Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX02	Pravastatin und Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX03	Atorvastatin und Amlodipin	WHO Anatomical Therapeutic Chemical classification
0‑L	D	Dermatika	WHO Anatomical Therapeutic Chemical classification
0‑L	D01	Antimykotika zur dermatologischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D01A	Antimykotika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA01	Nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA02	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA03	Hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA04	Pecilocin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA06	Mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA07	Pyrrolnitrin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA08	Griseofulvin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC	Imidazol- und Triazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC01	Clotrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC02	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC03	Econazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC04	Chlormidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC05	Isoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC06	Tiabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC07	Tioconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC08	Ketoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC09	Sulconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC10	Bifonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC11	Oxiconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC12	Fenticonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC13	Omoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC14	Sertaconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC15	Fluconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC16	Flutrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC52	Miconazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC60	Bifonazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE	Andere Antimykotika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE01	Bromchlorsalicylanilid	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE02	Methylrosanilin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE03	Tribrommetacresol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE04	Undecylensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE05	Polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE06	2-(4-chlorphenoxy)-ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE07	Chlorphenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE08	Ticlaton	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE09	Sulbentin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE10	Ethylhydroxybenzoat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE11	Haloprogin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE12	Salicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE13	Selendisulfid	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE14	Ciclopirox	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE15	Terbinafin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE16	Amorolfin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE17	Dimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE18	Tolnaftat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE19	Tolciclat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE21	Flucytosin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE22	Naftifin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE23	Butenafin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE54	Undecylensäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D01B	Antimykotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA	Antimykotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA01	Griseofulvin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA02	Terbinafin	WHO Anatomical Therapeutic Chemical classification
0‑L	D02	Emollientia und Hautschutzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02A	Emollientia und Hautschutzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AA	Silikon-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AB	Zink-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AC	Vaseline und Fett-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AD	Flüssige Pflaster	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE	Harnstoff-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE01	Harnstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE51	Harnstoff, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AF	Salicylsäure-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AX	Andere Emollientia und Hautschutzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D02B	Protektiva gegen UV-Strahlung	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA	Protektiva gegen UV-Strahlung zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA01	Aminobenzoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA02	Octinoxat	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB	Protektiva gegen UV-Strahlung zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB01	Betacaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	D03	Zubereitungen zur Behandlung von Wunden und Geschwüren	WHO Anatomical Therapeutic Chemical classification
0‑L	D03A	Wundbehandlungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AA	Lebertransalben	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX	Andere Wundbehandlungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX01	Cadexomer-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX02	Dextranomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX03	Dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX04	Calciumpantothenat	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX05	Hyaluronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX06	Becaplermin	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX07	Glyceroltrinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX08	Isosorbiddinitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX09	Crilanomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX10	Enoxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D03B	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA	Proteolytische Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA01	Trypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA02	Clostridiopeptidase	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA52	Clostridiopeptidase, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D04	Antipruriginosa, inkl. Antihistaminika, Anästhetika etc.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04A	Antipruriginosa, inkl. Antihistaminika, Anästhetika etc.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA	Antihistaminika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA01	Thonzylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA02	Mepyramin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA03	Thenalidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA04	Tripelennamin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA09	Chloropyramin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA10	Promethazin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA12	Tolpropamin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA13	Dimetinden	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA14	Clemastin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA15	Bamipin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA22	Isothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA32	Diphenhydramin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA33	Diphenhydraminmethylbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA34	Chlorphenoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB	Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB01	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB02	Cinchocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB03	Oxybuprocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB04	Benzocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB05	Chinisocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB06	Tetracain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB07	Pramocain	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AX	Andere Antipruriginosa	WHO Anatomical Therapeutic Chemical classification
0‑L	D05	Antipsoriatika	WHO Anatomical Therapeutic Chemical classification
0‑L	D05A	Antipsoriatika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AA	Teere	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC	Anthracen-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC01	Dithranol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC51	Dithranol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD	Psoralene zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD01	Trioxysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD02	Methoxsalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX	Andere Antipsoriatika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX01	Fumarsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX02	Calcipotriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX03	Calcitriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX04	Tacalcitol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX05	Tazaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX52	Calcipotriol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05B	Antipsoriatika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA	Psoralene zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA01	Trioxysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA02	Methoxsalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA03	Bergapten	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB	Retinoide zur Behandlung der Psoriasis	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB01	Etretinat	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB02	Acitretin	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX	Andere Antipsoriatika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX51	Fumarsäure-Derivate, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D06	Antibiotika und Chemotherapeutika zur Dermatologischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D06A	Antibiotika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA	Tetracyclin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA01	Demeclocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA02	Chlortetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA03	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA04	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX	Andere Antibiotika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX01	Fusidinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX02	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX04	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX05	Bacitracin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX07	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX08	Tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX09	Mupirocin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX10	Virginiamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX11	Rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX12	Amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX13	Retapamulin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06B	Chemotherapeutika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA	Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA01	Sulfadiazin-Silber	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA02	Sulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA03	Mafenid	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA04	Sulfamethizol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA05	Sulfanilamid	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA06	Sulfamerazin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA51	Sulfadiazin-Silber, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB	Antivirale Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB01	Idoxuridin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB02	Tromantadin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB03	Aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB04	Podophyllotoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB05	Inosin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB06	Penciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB07	Lysozym	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB08	Ibacitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB09	Edoxudin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB10	Imiquimod	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB11	Docosanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB53	Aciclovir, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX	Andere Chemotherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX01	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06C	Antibiotika und Chemotherapeutika, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07	Corticosteroide, Dermatologische Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07A	Corticosteroide, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA	Corticosteroide, schwach wirksam (Gruppe I)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA01	Methylprednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA02	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA03	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB	Corticosteroide, mittelstark wirksam (Gruppe II)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB01	Clobetason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB02	Hydrocortisonbutyrat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB03	Flumetason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB04	Fluocortin	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB05	Fluperolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB06	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB07	Flupredniden	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB08	Desonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB09	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB10	Alclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB11	Hydrocortisonbuteprat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB19	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB21	Clocortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB30	Kombinationen mittelstark wirksamer Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC	Corticosteroide, stark wirksam (Gruppe III)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC01	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC02	Fluclorolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC03	Desoximetason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC04	Fluocinolonacetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC05	Fluocortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC06	Diflucortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC07	Fludroxycortid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC08	Fluocinonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC09	Budesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC10	Diflorason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC11	Amcinonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC12	Halometason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC13	Mometason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC14	Methylprednisolonaceponat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC15	Beclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC16	Hydrocortisonaceponat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC17	Fluticason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC18	Prednicarbat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC19	Difluprednat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC21	Ulobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD	Corticosteroide, sehr stark wirksam (Gruppe IV)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD01	Clobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD02	Halcinonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07B	Corticosteroide, Kombinationen mit Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA	Corticosteroide, schwach wirksam, Kombinationen mit Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA01	Prednisolon und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA04	Hydrocortison und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB	Corticosteroide, mittelstark wirksam, Kombinationen mit Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB01	Flumetason und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB02	Desonid und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB03	Triamcinolon und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB04	Hydrocortisonbutyrat und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC	Corticosteroide, stark wirksam, Kombinationen mit Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC01	Betamethason und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC02	Fluocinolonacetonid und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC03	Fluocortolon und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC04	Diflucortolon und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BD	Corticosteroide, sehr stark wirksam, Kombinationen mit Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07C	Corticosteroide, Kombinationen mit Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA	Corticosteroide, schwach wirksam, Kombinationen mit Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA01	Hydrocortison und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA02	Methylprednisolon und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA03	Prednisolon und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB	Corticosteroide, mittelstark wirksam, Kombinationen mit Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB01	Triamcinolon und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB02	Flupredniden und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB03	Fluorometholon und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB04	Dexamethason und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB05	Flumetason und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC	Corticosteroide, stark wirksam, Kombinationen mit Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC01	Betamethason und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC02	Fluocinolonacetonid und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC03	Fludroxycortid und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC04	Beclometason und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC05	Fluocinonid und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC06	Fluocortolon und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD	Corticosteroide, sehr stark wirksam, Kombinationen mit Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD01	Clobetasol und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D07X	Corticosteroide, Andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA	Corticosteroide, schwach wirksam, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA01	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA02	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB	Corticosteroide, mittelstark wirksam, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB01	Flumetason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB02	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB03	Flupredniden	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB04	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB05	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB30	Kombinationen mittelstark wirksamer Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC	Corticosteroide, stark wirksam, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC01	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC02	Desoximetason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC03	Mometason	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC04	Diflucortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XD	Corticosteroide, sehr stark wirksam, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08	Antiseptika und Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08A	Antiseptika und Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA	Acridin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA01	Ethacridinlactat	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA02	Aminoacridin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA03	Euflavin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AB	Aluminium-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC	Biguanide und Amidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC01	Dibrompropamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC02	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC03	Propamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC04	Hexamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC05	Polihexanid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC52	Chlorhexidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AD	Borsäure-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE	Phenol und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE01	Hexachlorophen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE02	Policresulen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE03	Phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE04	Triclosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE05	Chloroxylenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE06	Biphenylol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF	Nitrofuran-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF01	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG	Iod-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG01	Iodoctylphenoxypolyglycolether	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG02	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG03	Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG04	Diiodhydroxypropan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH	Chinolin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH01	Dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH02	Chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH03	Oxichinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH30	Clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ	Quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ01	Benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ02	Cetrimonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ03	Cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ04	Cetrimid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ05	Benzoxoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ06	Didecyldimethylammoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ57	Octenidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ58	Benzethoniumchlorid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ59	Dodecloniumbromid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK	Quecksilber-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK01	Quecksilberamidochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK02	Phenylmercuriborat	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK03	Quecksilberchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK04	Merbromin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK05	Metallisches Quecksilber	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK06	Thiomersal	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK30	Quecksilberiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL	Silber-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL01	Silbernitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL30	Silber	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX	Andere Antiseptika und Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX01	Wasserstoffperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX02	Eosin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX03	Propanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX04	Tosylchloramid-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX05	Isopropanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX06	Kaliumpermanganat	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX07	Natriumhypochlorit	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX08	Ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX53	Propanol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D09	Medizinische Verbände	WHO Anatomical Therapeutic Chemical classification
0‑L	D09A	Medizinische Verbände	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA	Medizinische verbände mit Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA01	Framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA02	Fusidinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA03	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA04	Phenylquecksilbernitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA05	Benzododecinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA06	Triclosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA07	Cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA08	Aluminiumhydroxychlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA09	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA10	Clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA11	Benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA12	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA13	Iodoform	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB	Zink-haltige Verbände	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB01	Zink-haltige Verbände ohne Zusätze	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB02	Zink-haltige Verbände mit Zusätzen	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AX	Vaselin-haltige Verbände	WHO Anatomical Therapeutic Chemical classification
0‑L	D10	Aknemittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D10A	Aknemittel zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA	Corticosteroide, Kombinationen zur Behandlung der Akne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA01	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA02	Methylprednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA03	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB	Schwefel-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB01	Bithionol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB02	Schwefel	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB03	Tioxolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB05	Mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD	Retinoide zur topischen Anwendung bei Akne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD01	Tretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD02	Retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD03	Adapalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD04	Isotretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD05	Motretinid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD51	Tretinoin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD53	Adapalen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD54	Isotretinoin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE	Peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE01	Benzoylperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE51	Benzoylperoxid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF	Antiinfektiva zur Behandlung der Akne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF01	Clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF02	Erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF03	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF04	Meclocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF51	Clindamycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF52	Erythromycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX	Andere Aknemittel zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX01	Aluminiumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX02	Resorcin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX03	Azelainsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX04	Aluminiumoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX30	Verschiedene Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10B	Aknemittel zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA	Retinoide zur Behandlung der Akne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA01	Isotretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX	Andere Aknemittel zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX01	Natriumbituminosulfonat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11	Andere Dermatika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11A	Andere Dermatika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AA	Antihidrotika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC	Medizinische Haarwaschmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC01	Cetrimid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC02	Cadmium-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC03	Selen-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC06	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC08	Schwefel-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC09	Xenysalat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC30	Andere	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE	Androgene zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE01	Metandienon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AF	Warzenmittel und Keratolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH02	Pimecrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH04	Alitretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX	Andere Dermatika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX01	Minoxidil	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX02	Gamolensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX03	Calciumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX04	Lithiumsuccinat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX05	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX06	Mequinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX08	Tiratricol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX09	Oxaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX10	Finasterid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX11	Hydrochinon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX12	Pyrithion zink	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX13	Monobenzon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX14	Tacrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX15	Pimecrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX16	Eflornithin	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX17	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX18	Diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX19	Alitretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX52	Gamolensäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX57	Kollagen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G	Urogenitalsystem und Sexualhormone	WHO Anatomical Therapeutic Chemical classification
0‑L	G01	Gynäkologische Antiinfektiva und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	G01A	Antiinfektiva und Antiseptika, exkl. Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA01	Nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA02	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA03	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA04	Candicidin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA05	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA06	Hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA07	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA08	Carfecillin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA09	Mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA10	Clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA11	Pentamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA51	Nystatin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB	Arsen-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB01	Acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC	Chinolin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC01	Diiodhydroxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC02	Clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC03	Chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC05	Dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC06	Broxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC30	Oxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD	Organische Säuren	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD01	Milchsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD02	Essigsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD03	Ascorbinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE	Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE01	Sulfatolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE10	Kombinationen von Sulfonamiden	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF	Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF01	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF02	Clotrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF04	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF05	Econazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF06	Ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF07	Isoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF08	Tioconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF11	Ketoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF12	Fenticonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF13	Azanidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF14	Propenidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF15	Butoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF16	Omoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF17	Oxiconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF18	Flutrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF20	Kombinationen von Imidazol-Derivaten	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG	Triazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG02	Terconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX	Andere Antiinfektiva und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX01	Clodantoin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX02	Inosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX03	Policresulen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX05	Nifuratel	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX06	Furazolidon	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX09	Methylrosanilin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX11	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX12	Ciclopirox	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX13	Protiofat	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX14	Lactobacillus-Ferment	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX15	Kupferusnat	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX66	Octenidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01B	Antiinfektiva/Antiseptika in Kombination mit Corticosteroiden	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BA	Antibiotika und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BC	Chinolin-Derivate und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BD	Antiseptika und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BE	Sulfonamide und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BF	Imidazol-Derivate und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	G02	Andere Gynäkologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G02A	Wehen fördernde Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB	Mutterkorn-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB01	Methylergometrin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB02	Mutterkorn-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB03	Ergometrin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC	Mutterkorn-Alkaloide und Oxytocin inkl. Derivate, in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC01	Methylergometrin und Oxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD	Prostaglandine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD01	Dinoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD02	Dinoproston	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD03	Gemeprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD04	Carboprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD05	Sulproston	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD06	Misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AX	Andere Wehen fördernde Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	G02B	Kontrazeptiva zur lokalen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA	Intrauterine Kontrazeptiva	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA01	Plastik-IUP	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA02	Plastik-IUP mit Kupfer	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA03	Plastik-IUP mit Progesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB	Intravaginale Kontrazeptiva	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB01	Vaginalring mit Gestagenen und Estrogenen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02C	Andere Gynäkologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA	Sympathomimetika, Wehen hemmend	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA01	Ritodrin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA02	Buphenin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA03	Fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB	Prolactinhemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB01	Bromocriptin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB02	Lisurid	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB03	Cabergolin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB04	Quinagolid	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB05	Metergolin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC	Antiphlogistika zur vaginalen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC01	Ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC02	Naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC03	Benzydamin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC04	Flunoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX	Andere Gynäkologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX01	Atosiban	WHO Anatomical Therapeutic Chemical classification
0‑L	G03	Sexualhormone und Modulatoren des Genitalsystems	WHO Anatomical Therapeutic Chemical classification
0‑L	G03A	Hormonelle Kontrazeptiva zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA	Gestagene und Estrogene, fixe Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA01	Etynodiol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA02	Quingestanol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA03	Lynestrenol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA04	Megestrol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA05	Norethisteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA06	Norgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA07	Levonorgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA08	Medroxyprogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA09	Desogestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA10	Gestoden und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA11	Norgestimat und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA12	Drospirenon und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA13	Norelgestromin und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA14	Nomegestrol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA15	Chlormadinon und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB	Gestagene und Estrogene, Sequenzialpräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB01	Megestrol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB02	Lynestrenol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB03	Levonorgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB04	Norethisteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB05	Desogestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB06	Gestoden und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB07	Chlormadinon und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB08	dienogest and estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC	Gestagene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC01	Norethisteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC02	Lynestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC03	Levonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC04	Quingestanol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC05	Megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC06	Medroxyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC07	Norgestrienon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC08	Etonogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC09	Desogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD01	Levonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03B	Androgene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA	3-Oxoandrosten-4-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA01	Fluoxymesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA02	Methyltestosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA03	Testosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB	5-Androstanon-3-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB01	Mesterolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB02	Androstanolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03C	Estrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA	Natürliche und halbsynthetische Estrogene, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA01	Ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA03	Estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA04	Estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA06	Chlorotrianisen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA07	Estron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA09	Promestrien	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA53	Estradiol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA57	Konjugierte Estrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB	Synthetische Estrogene, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB01	Dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB02	Diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB03	Methallenestril	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB04	Moxestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC	Estrogene, Kombinationen mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC02	Dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC03	Methallenestril	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC04	Estron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC05	Diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC06	Estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CX01	Tibolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03D	Gestagene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA	Pregnen-4-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA01	Gestonoron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA02	Medroxyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA03	Hydroxyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA04	Progesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB	Pregnadien-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB01	Dydrogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB02	Megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB03	Medrogeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB04	Nomegestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB05	Demegeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB06	Chlormadinon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB07	Promegeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB08	Dienogest	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC	Estren-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC01	Allylestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC02	Norethisteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC03	Lynestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC04	Ethisteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC05	Tibolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC06	Etynodiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC31	Methylestrenolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03E	Androgene und weibliche Sexualhormone in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA	Androgene und Estrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA01	Methyltestosteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA02	Testosteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA03	Prasteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EB	Androgen, Gestagen und Estrogen in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK	Androgene und weibliche Sexualhormone in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK01	Methyltestosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03F	Gestagene und Estrogene in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA	Gestagene und Estrogene, fixe Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA01	Norethisteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA02	Hydroxyprogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA03	Ethisteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA04	Progesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA05	Methylnortestosteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA06	Etynodiol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA07	Lynestrenol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA08	Megestrol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA09	Noretynodrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA10	Norgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA11	Levonorgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA12	Medroxyprogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA13	Norgestimat und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA14	Dydrogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA15	Dienogest und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA16	Trimegeston und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA17	Drospirenon und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB	Gestagene und Estrogene, Sequenzialpräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB01	Norgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB02	Lynestrenol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB03	Chlormadinon und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB04	Megestrol und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB05	Norethisteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB06	Medroxyprogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB07	Medrogeston und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB08	Dydrogesteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB09	Levonorgestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB10	Desogestrel und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB11	Trimegeston und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03G	Gonadotropine und andere Ovulationsauslöser	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA	Gonadotropine	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA01	Choriongonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA02	Humanes menopausales Gonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA03	Serumgonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA04	Urofollitropin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA05	Follitropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA06	Follitropin beta	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA07	Lutropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA08	Choriongonadotropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA09	Corifollitropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB	Ovulationsauslöser, synthetisch	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB01	Cyclofenil	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB02	Clomifen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB03	Epimestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03H	Antiandrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA	Antiandrogene, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA01	Cyproteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB	Antiandrogene und Estrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB01	Cyproteron und Estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03X	Andere Sexualhormone und Modulatoren des Genitalsystems	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA	Antigonadotropine und ähnliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA01	Danazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA02	Gestrinon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB	Antigestagene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB01	Mifepriston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC	Selektive Estrogenrezeptor-Modulatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC01	Raloxifen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC02	Bazedoxifen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04	Urologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G04A	Urinary antiseptics and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AA	Methenamine preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AB	Quinolone derivatives (excl. J01M)	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AC	Nitrofuran derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AD	Salicylates	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AG	Other urinary antiseptics and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AH	Sulfonamides in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	G04AK	Urinary antiseptics and antiinfectives comb., excl. sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	G04B	Andere Urologika, inkl. Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA	Harn ansäuernde Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA01	Ammoniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA03	Calciumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BC	Harnkonkrement lösende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD	Urologische Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD01	Emepronium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD02	Flavoxat	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD03	Meladrazin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD04	Oxybutynin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD05	Terodilin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD06	Propiverin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD07	Tolterodin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD08	Solifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD09	Trospium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD10	Darifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD11	Fesoterodin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE	Mittel bei erektiler Dysfunktion	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE01	Alprostadil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE02	Papaverin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE03	Sildenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE04	Yohimbin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE05	Phentolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE06	Moxisylyt	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE07	Apomorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE08	Tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE09	Vardenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE52	Papaverin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BP30	Pflanzliche Urologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX	Andere Urologika	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX01	Magnesiumhydroxid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX03	Acetohydroxamsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX06	Phenazopyridin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX10	Succinimid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX11	Collagen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX12	Phenylsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX13	Dimethylsulfoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX14	Dapoxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04C	Mittel bei Benigner Prostatahyperplasie	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA	Alpha-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA01	Alfuzosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA02	Tamsulosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA03	Terazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA04	Silodosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA52	Tamsulosin und Dutasterid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA53	Tamsulosin und Solifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB	Testosteron-5-alfa-Reduktasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB01	Finasterid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB02	Dutasterid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX	Andere Mittel bei benigner Prostatahyperplasie	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX01	Pygeum africanum	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX02	Serenoa repens	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX03	Mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	H	Systemische Hormonpräparate, exkl. Sexualhormone und Insuline	WHO Anatomical Therapeutic Chemical classification
0‑L	H01	Hypophysen- und Hypothalamushormone und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H01A	Hypophysenvorderlappenhormone und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA	ACTH	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA01	Corticotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA02	Tetracosactid	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB	Thyrotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB01	Thyrotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC	Somatropin und Somatropin-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC01	Somatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC02	Somatrem	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC03	Mecasermin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC04	Sermorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX	Andere Hypophysenvorderlappenhormone und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX01	Pegvisomant	WHO Anatomical Therapeutic Chemical classification
0‑L	H01B	Hypophysenhinterlappenhormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA	Vasopressin und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA01	Vasopressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA02	Desmopressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA03	Lypressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA04	Terlipressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA05	Ornipressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA06	Argipressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB	Oxytocin und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB01	Demoxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB02	Oxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB03	Carbetocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01C	Hypothalamushormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA	Gonadotropin-Releasing-Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA01	Gonadorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA02	Nafarelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA03	Histrelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA93	Gonadotrophin-releasing hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB	Anti-Wachstumshormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB01	Somatostatin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB02	Octreotid	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB03	Lanreotid	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC	Gonadotropin-Releasing-Hormon-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC01	Ganirelix	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC02	Cetrorelix	WHO Anatomical Therapeutic Chemical classification
0‑L	H02	Corticosteroide zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	H02A	Corticosteroide zur systemischen Anwendung, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA	Mineralocorticoide	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA01	Aldosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA02	Fludrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA03	Desoxycorton	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB	Glucocorticoide	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB01	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB02	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB03	Fluocortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB04	Methylprednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB05	Paramethason	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB06	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB07	Prednison	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB08	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB09	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB10	Cortison	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB11	Prednyliden	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB12	Rimexolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB13	Deflazacort	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB14	Cloprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB15	Meprednison	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB17	Cortivazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02B	Corticosteroide zur systemischen Anwendung, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX	Corticosteroide zur systemischen Anwendung, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX01	Methylprednisolon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	H02C	Nebennierenhemmstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA	Anticorticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA01	Trilostan	WHO Anatomical Therapeutic Chemical classification
0‑L	H03	Schilddrüsentherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	H03A	Schilddrüsenpräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA	Schilddrüsenhormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA01	Levothyroxin-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA02	Liothyronin-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA03	Kombinationen von Levothyroxin und Liothyronin	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA04	Tiratricol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA05	Zubereitungen aus Schilddrüsengewebe	WHO Anatomical Therapeutic Chemical classification
0‑L	H03B	Thyreostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA	Thiouracile	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA01	Methylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA02	Propylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA03	Benzylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB	Schwefel-haltige Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB01	Carbimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB02	Thiamazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB52	Thiamazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC	Perchlorate	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC01	Kaliumperchlorat	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX	Andere Thyreostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX01	Diiodtyrosin	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX02	Dibromtyrosin	WHO Anatomical Therapeutic Chemical classification
0‑L	H03C	Iodtherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	H03CA	Iodtherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	H04	Pankreashormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H04A	Glykogenolytische Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA	Glykogenolytische Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA01	Glucagon	WHO Anatomical Therapeutic Chemical classification
0‑L	H05	Calciumhomöostase	WHO Anatomical Therapeutic Chemical classification
0‑L	H05A	Nebenschilddrüsenhormone und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA	Nebenschilddrüsenhormone und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA01	Nebenschilddrüsenextrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA02	Teriparatid	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA03	Parathyroid Hormon	WHO Anatomical Therapeutic Chemical classification
0‑L	H05B	Nebenschilddrüsen-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA	Calcitonin-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA01	Calcitonin (Lachs, synthetisch)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA02	Calcitonin (Schwein, natürlich)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA03	Calcitonin (Mensch, synthetisch)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA04	Elcatonin	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX	Andere Nebenschilddrüsen-antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX01	Cinacalcet	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX02	Paricalcitol	WHO Anatomical Therapeutic Chemical classification
0‑L	I07AA	inactivated viral vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	I07AA06	Canine Herpesvirus vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	I09AA07	Inactivated Porcine Circovirus vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	J	Antiinfektiva zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J01	Antibiotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J01A	Tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA	Tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA01	Demeclocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA02	Doxycyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA03	Chlortetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA04	Lymecyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA05	Metacyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA06	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA07	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA08	Minocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA09	Rolitetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA10	Penimepicyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA11	Clomocyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA12	Tigecyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA20	Kombinationen von Tetracyclinen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA56	Oxytetracyclin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01B	Amphenicole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA	Amphenicole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA01	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA02	Thiamphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA52	Thiamphenicol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01C	Betalactam-Antibiotika, Penicilline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA	Penicilline mit erweitertem Wirkungsspektrum	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA01	Ampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA02	Pivampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA03	Carbenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA04	Amoxicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA05	Carindacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA06	Bacampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA07	Epicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA08	Pivmecillinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA09	Azlocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA10	Mezlocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA11	Mecillinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA12	Piperacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA13	Ticarcillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA14	Metampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA15	Talampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA16	Sulbenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA17	Temocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA18	Hetacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA51	Ampicillin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE	Beta-Lactamase-sensitive Penicilline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE01	Benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE02	Phenoxymethylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE03	Propicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE04	Azidocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE05	Pheneticillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE06	Penamecillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE07	Clometocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE08	Benzylpenicillin-Benzathin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE09	Benzylpenicillin-procain	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE10	Phenoxymethylpenicillin-Benzathin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF	Beta-Lactamase-resistente Penicilline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF01	Dicloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF02	Cloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF03	Meticillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF04	Oxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF05	Flucloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG	Beta-Lactamase-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG01	Sulbactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG02	Tazobactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR	Kombinationen von Penicillinen, inkl. Beta-Lactamase-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR01	Ampicillin und Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR02	Amoxicillin und Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR03	Ticarcillin und Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR04	Sultamicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR05	Piperacillin und Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR50	Kombinationen von Penicillinen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01D	Andere Beta-Lactam-Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DA	Cephalosporins and related substances *	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB	Cephalosporine der 1. Generation	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB01	Cefalexin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB02	Cefaloridin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB03	Cefalotin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB04	Cefazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB05	Cefadroxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB06	Cefazedon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB07	Cefatrizin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB08	Cefapirin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB09	Cefradin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB10	Cefacetril	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB11	Cefroxadin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB12	Ceftezol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC	Cephalosporine der 2. Generation	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC01	Cefoxitin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC02	Cefuroxim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC03	Cefamandol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC04	Cefaclor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC05	Cefotetan	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC06	Cefonicid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC07	Cefotiam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC08	Loracarbef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC09	Cefmetazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC10	Cefprozil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC11	Ceforanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD	Cephalosporine der 3. Generation	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD01	Cefotaxim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD02	Ceftazidim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD03	Cefsulodin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD04	Ceftriaxon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD05	Cefmenoxim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD06	Latamoxef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD07	Ceftizoxim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD08	Cefixim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD09	Cefodizim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD10	Cefetamet	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD11	Cefpiramid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD12	Cefoperazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD13	Cefpodoxim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD14	Ceftibuten	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD15	Cefdinir	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD16	Cefditoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD54	Ceftriaxon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD62	Cefoperazon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD91	Cefovecin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE	Cephalosporine der 4. Generation	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE01	Cefepim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE02	Cefpirom	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF	Monobactame	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF01	Aztreonam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH	Carbapeneme	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH02	Meropenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH03	Ertapenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH04	Doripenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH51	Imipenem und Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI02	Ceftarolin fosamil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01E	Sulfonamide und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA	Trimethoprim und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA01	Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA02	Brodimoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB	Kurz wirkende Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB01	Sulfaisodimidin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB02	Sulfamethizol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB03	Sulfadimidin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB04	Sulfapyridin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB05	Sulfafurazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB06	Sulfanilamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB07	Sulfathiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB08	Sulfathiourea	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC	Mittellang wirkende Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC01	Sulfamethoxazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC02	Sulfadiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC03	Sulfamoxol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED	Lang wirkende Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED01	Sulfadimethoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED02	Sulfalen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED03	Sulfametomidin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED04	Sulfametoxydiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED05	Sulfamethoxypyridazin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED06	Sulfaperin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED07	Sulfamerazin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED08	Sulfaphenazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED09	Sulfamazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE	Kombinationen von Sulfonamiden und Trimethoprim, inkl. Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE01	Sulfamethoxazol und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE02	Sulfadiazin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE03	Sulfametrol und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE04	Sulfamoxol und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE05	Sulfadimidin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE06	Sulfadiazin und Tetroxoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE07	Sulfamerazin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01F	Makrolide, Lincosamide und Streptogramine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA	Makrolide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA01	Erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA02	Spiramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA03	Midecamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA05	Oleandomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA06	Roxithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA07	Josamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA08	Troleandomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA09	Clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA10	Azithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA11	Miocamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA12	Rokitamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA13	Dirithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA14	Flurithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA15	Telithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA95	Gamithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF	Lincosamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF01	Clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF02	Lincomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG	Streptogramine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG01	Pristinamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG02	Quinupristin/Dalfopristin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01G	Aminoglykosid-Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA	Streptomycine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA01	Streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA02	Streptoduocin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB	Andere Aminoglykoside	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB01	Tobramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB03	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB04	Kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB05	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB06	Amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB07	Netilmicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB08	Sisomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB09	Dibekacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB10	Ribostamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB11	Isepamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01M	Chinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA	Fluorchinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA01	Ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA02	Ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA03	Pefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA04	Enoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA05	Temafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA06	Norfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA07	Lomefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA08	Fleroxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA09	Sparfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA10	Rufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA11	Grepafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA12	Levofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA13	Trovafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA14	Moxifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA15	Gemifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA16	Gatifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA17	Prulifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA18	Pazufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA19	Garenoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB	Andere Chinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB01	Rosoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB02	Nalidixinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB03	Piromidsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB04	Pipemidsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB05	Oxolinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB06	Cinoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB07	Flumequin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01R	Kombinationen von Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA	Kombinationen von Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA01	Penicilline, Kombination mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA02	Sulfonamide, Kombination mit anderen Antibiotika (exkl. Trimethoprim)	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA03	Cefuroxim, Kombination mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA04	Spiramycin, Kombination mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01X	Andere Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA	Glycopeptid-Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA01	Vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA02	Teicoplanin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB	Polymyxine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB01	Colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB02	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC	Steroid-Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC01	Fusidinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD	Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD01	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD02	Tinidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD03	Ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE	Nitrofuran-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE01	Nitrofurantoin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE02	Nifurtoinol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX	Andere Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX01	Fosfomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX02	Xibornol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX03	Clofoctol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX04	Spectinomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX05	Methenamin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX06	Mandelsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX07	Nitroxolin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX08	Linezolid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX09	Daptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02	Antimykotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J02A	Antimykotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA01	Amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA02	Hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB	Imidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB01	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB02	Ketoconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC	Triazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC01	Fluconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC02	Itraconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC03	Voriconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC04	Posaconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX	Andere Antimykotika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX01	Flucytosin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX04	Caspofungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX05	Micafungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX06	Anidulafungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04	Mittel gegen Mykobakterien	WHO Anatomical Therapeutic Chemical classification
0‑L	J04A	Mittel zur Behandlung der Tuberkulose	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA	Aminosalicylsäure und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA01	Aminosalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA02	Natriumaminosalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA03	Calciumaminosalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB01	Cycloserin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB02	Rifampicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB03	Rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB04	Rifabutin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB05	Rifapentin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB30	Capreomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC	Hydrazide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC01	Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC51	Isoniazid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD	Thiocarbamid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD01	Protionamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD02	Tiocarlid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD03	Ethionamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK	Andere Mittel zur Behandlung der Tuberkulose	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK01	Pyrazinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK02	Ethambutol	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK03	Terizidon	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK04	Morinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM	Kombinationen von Mitteln zur Behandlung der Tuberkulose	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM01	Streptomycin und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM02	Rifampicin und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM03	Ethambutol und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM04	Thioacetazon und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM05	Rifampicin, Pyrazinamid und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM06	Rifampicin, Pyrazinamid, Ethambutol und Isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04B	Mittel zur Behandlung der Lepra	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA	Mittel zur Behandlung der Lepra	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA01	Clofazimin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA02	Dapson	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA03	Aldesulfonnatrium	WHO Anatomical Therapeutic Chemical classification
0‑L	J05	Antivirale Mittel zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J05A	Direkt wirkende antivirale Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA	Thiosemicarbazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA01	Metisazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB	Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB01	Aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB02	Idoxuridin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB03	Vidarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB04	Ribavirin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB06	Ganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB09	Famciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB11	Valaciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB12	Cidofovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB13	Penciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB14	Valganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB15	Brivudin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC	Cyclische Amine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC02	Rimantadin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC03	Tromantadin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD	Phosphonsäure-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD01	Foscarnet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD02	Fosfonet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE	Proteasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE01	Saquinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE02	Indinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE03	Ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE04	Nelfinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE05	Amprenavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE06	Lopinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE07	Fosamprenavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE08	Atazanavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE09	Tipranavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE10	Darunavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF	Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF01	Zidovudin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF02	Didanosin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF03	Zalcitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF04	Stavudin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF05	Lamivudin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF06	Abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF07	Tenofovir Disoproxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF08	Adefovir dipivoxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF09	Emtricitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF10	Entecavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF11	Telbivudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG	Nicht-Nukleosidale Inhibitoren der Reverse-Transkriptase	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG01	Nevirapin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG02	Delavirdin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG03	Efavirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG04	Etravirin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH	Neuraminidasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH01	Zanamivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH02	Oseltamivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR	Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR01	Ziduvudin und Lamivudin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR02	Lamivudin und Abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR03	Tenofovir disoproxil und Emtricitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR04	Zidovudin, Lamivudin und Abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR05	Zidovudin, Lamivudin und Nevirapin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR06	Emtricitabin, Tenofovir disoproxil und Efavirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX	Andere antivirale Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX01	Moroxydin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX02	Lysozym	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX05	Inosin-Pranobex	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX06	Pleconaril	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX07	Enfuvirtid	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX08	Raltegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX09	Maraviroc	WHO Anatomical Therapeutic Chemical classification
0‑L	J06	Immunsera und Immunglobuline	WHO Anatomical Therapeutic Chemical classification
0‑L	J06A	Immunsera	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA	Immunsera	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA01	Diphtherie-Antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA02	Tetanus-Antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA03	Schlangengift-Antiserum	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA04	Botulinum-Antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA05	Gasbrand-Serum	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA06	Tollwut-Serum	WHO Anatomical Therapeutic Chemical classification
0‑L	J06B	Immunglobuline	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA	Immunglobuline, normal human	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA01	Immunglobuline, normal human, zur extravasalen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA02	Immunglobuline, normal human, zur intravasalen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB	Spezifische Immunglobuline	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB01	Anti-D(rh)-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB02	Tetanus-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB03	Varicella/Zoster-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB04	Hepatitis B-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB05	Tollwut-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB06	Röteln-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB07	Kuhpocken-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB08	Staphylococcus-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB09	Cytomegalievirus-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB10	Diphtherie-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB11	Hepatitis-A-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB12	FSME-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB13	Pertussis-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB14	Masern-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB15	Mumps-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB16	Palivizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC	Andere Immunglobuline	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC01	Nebacumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J07	Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07A	Bakterielle Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC	Milzbrand-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC01	Anthrax-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD	Brucellose-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD01	Brucella-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE	Cholera-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE01	Cholera, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE02	Cholera, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE51	Cholera, Kombinationen mit Typhus-Impfstoff, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF	Diphtherie-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF01	Diphtherie-Toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG	Haemophilus-influenza-B-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG01	Haemophilus-influenzae B, gereinigtes Antigen konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG51	Haemophilus-influenzae B, Kombinationen mit Toxoiden	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG52	Haemophilus-influenzae B, Kombinationen mit Pertussis und Toxoiden	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG53	Haemophilus-influenzae B, Kombinationen mit Meningokokkus C, konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH	Meningokokken-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH01	Meningokokkus A, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH02	Andere Meningokokken monovalent, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH03	Meningokokkus bivalent, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH04	Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH05	Andere Meningokokken polyvalent, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH06	Meningokokkus B, Äußeres-Membranvesikel-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH07	Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH08	Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ	Pertussis-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ01	Pertussis, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ02	Pertussis, gereinigtes Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ51	Pertussis, inaktiviert, ganze Zelle, Kombinationen mit Toxoiden	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ52	Pertussis, gereinigtes Antigen, Kombinationen mit Toxoiden	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK	Pest-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK01	Pest, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL	Pneumokokken-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL01	Pneumokokken, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL02	Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM	Tetanus-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM01	Tetanus-Toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM51	Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM52	Tetanus-Toxoid, Kombinationen mit Tetanus-Immunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN	Tuberkulose-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN01	Tuberkulose, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP	Typhus-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP01	Typhus, oral, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP02	Typhus, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP03	Typhus, gereinigtes Polysaccharid-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP10	Typhus, Kombinationen mit Paratyphustypen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR	Typhus (exanthematicus)-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR01	Typhus exanthematicus, inaktiviert, ganze Zelle	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AX	Andere bakterielle Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07B	Virale Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA	Encephalitis-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA01	FSME, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA02	Encephalitis, japanische, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB	Influenza-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB01	Influenza, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB02	Influenza, gereinigtes Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC	Hepatitis-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC01	Hepatitis B, gereinigtes Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC02	Hepatitis A, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD	Masern-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD01	Masern, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD51	Masern, Kombinationen mit Mumps, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD52	Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD53	Masern, Kombinationen mit Röteln, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD54	Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE	Mumps-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE01	Mumps, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF	Poliomyelitis-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF01	Poliomyelitis, oral, monovalent, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF02	Poliomyelitis, oral, trivalent, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF03	Poliomyelitis, trivalent, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG	Tollwut-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG01	Tollwut, inaktiviert, ganzes Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH	Rotavirus-Diarrhoe-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH01	Rotavirus, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH02	Rotavirus, pentavalent, lebend, Reassortanten	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ	Röteln-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ01	Röteln, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ51	Röteln, Kombinationen mit Mumps, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK	Varicella Zoster Impfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK01	Varicella, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK02	Zoster Virus lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL	Gelbfieber-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL01	Gelbfieber, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM	Papillomvirus-Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM01	Humaner Papillomvirus-Impfstoff (Typen 6,11,16,18)	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM02	Humaner Papillomvirus-Impfstoff (Typen 16,18)	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX	Varicella, lebend abgeschwächt	WHO Anatomical Therapeutic Chemical classification
0‑L	J07C	Bakterielle und virale Impfstoffe, kombiniert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA	Bakterielle und virale Impfstoffe, kombiniert	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA01	Diphtherie-Poliomyelitis-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA02	Diphtherie-Pertussis-Poliomyelitis-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA03	Diphtherie-Röteln-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA04	Haemophilus-influenzae B und Poliomyelitis	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA05	Diphtherie-Hepatitis B-Pertussis-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA06	Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA07	Diphtherie-Hepatitis B-Tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA08	Hämophilus influenzae B und Hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA09	Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA10	Typhus-Hepatitis A	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA11	Diphtherie-Haemophilus-influenzae B-Pertussis-Tetanus-Hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA12	Diphtherie-Pertussis-Poliomyelitis-Tetanus-Hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07X	Andere Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	J51DB90	Cefalonium	WHO Anatomical Therapeutic Chemical classification
0‑L	L	Antineoplastische und Immunmodulierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01	Antineoplastische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01A	Alkylierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA	Stickstofflost-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA01	Cyclophosphamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA02	Chlorambucil	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA03	Melphalan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA05	Chlormethin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA06	Ifosfamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA07	Trofosfamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA08	Prednimustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA09	Bendamustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB	Alkylsulfonate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB01	Busulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB02	Treosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB03	Mannosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC	Ethylenimine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC01	Thiotepa	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC02	Triaziquon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC03	Carboquon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD	Nitrosoharnstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD01	Carmustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD02	Lomustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD03	Semustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD04	Streptozocin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD05	Fotemustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD06	Nimustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD07	Ranimustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG	Epoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG01	Etoglucid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX	Andere alkylierende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX01	Mitobronitol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX02	Pipobroman	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX03	Temozolomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX04	Dacarbazin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01B	Antimetabolite	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA	Folsäure-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA01	Methotrexat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA03	Raltitrexed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA04	Pemetrexed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB	Purin-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB02	Mercaptopurin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB03	Tioguanin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB04	Cladribin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB05	Fludarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB06	Clofarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB07	Nelarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC	Pyrimidin-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC01	Cytarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC02	Fluorouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC03	Tegafur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC04	Carmofur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC05	Gemcitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC06	Capecitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC08	Decitabin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC52	Fluorouracil, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC53	Tegafur, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01C	Pflanzliche Alkaloide und andere Natürliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA	Vinka-Alkaloide und Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA01	Vinblastin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA02	Vincristin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA03	Vindesin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA04	Vinorelbin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB	Podophyllotoxin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB01	Etoposid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB02	Teniposid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC	Colchicin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC01	Demecolcin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD	Taxane	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD01	Paclitaxel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD02	Docetaxel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX	Andere pflanzliche Alkaloide und natürliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX01	Trabectedin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01D	Zytotoxische Antibiotika und verwandte Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA	Actinomycine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA01	Dactinomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB	Anthracycline und verwandte Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB01	Doxorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB02	Daunorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB03	Epirubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB04	Aclarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB05	Zorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB06	Idarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB07	Mitoxantron	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB08	Pirarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB09	Valrubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB11	Pixantron	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC	Andere zytotoxische Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC01	Bleomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC02	Plicamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC03	Mitomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01X	Andere antineoplastische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA	Platin-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA01	Cisplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA02	Carboplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA03	Oxaliplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB	Methylhydrazine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB01	Procarbazin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC	Monoklonale Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC01	Edrecolomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC02	Rituximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC03	Trastuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC04	Alemtuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC05	Gemtuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC06	Cetuximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC07	Bevacizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC08	Panitumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC09	Catumaxomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC10	Ofatumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC11	Ipilimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD	Sensibilisatoren für die photodynamische/Radio- Therapie	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD01	Porfimer natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD03	Methylaminolevulinat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD04	Aminolevulin-Säure	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD05	Temoporfin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD06	Efaproxiral	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE	Proteinkinase Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE01	Imatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE02	Gefitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE03	Erlotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE04	Sunitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE05	Sorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE06	Dasatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE07	Lapatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE08	Nilotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE09	Temsirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XE11	Pazopanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX	Andere antineoplastische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX01	Amsacrin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX02	Asparaginase	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX03	Altretamin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX05	Hydroxycarbamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX07	Lonidamin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX08	Pentostatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX09	Miltefosin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX10	Masoprocol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX11	Estramustin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX14	Tretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX16	Mitoguazon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX17	Topotecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX18	Tiazofurin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX19	Irinotecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX22	Alitretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX23	Mitotan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX24	Pegaspargase	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX25	Bexaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX27	Arsentrioxid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX29	Denileukin diftitox	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX32	Bortezomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX33	Celecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX35	Anagrelid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY	Kombinationen von antineoplastischen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	L02	Endokrine Therapie	WHO Anatomical Therapeutic Chemical classification
0‑L	L02A	Hormone und verwandte Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA	Estrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA01	Diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA02	Polyestradiolphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA03	Ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA04	Fosfestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB	Gestagene	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB01	Megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB02	Medroxyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB03	Gestonoron	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE	Gonadotropin-Releasing-Hormon-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE01	Buserelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE02	Leuprorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE03	Goserelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE04	Triptorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AX	Andere Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	L02B	Hormonantagonisten und verwandte Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA	Antiestrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA01	Tamoxifen	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA02	Toremifen	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA03	Fulvestrant	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB	Antiandrogene	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB01	Flutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB02	Nilutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB03	Bicalutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG	Enzym-Inhibitoren	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG01	Aminoglutethimid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG02	Formestan	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG03	Anastrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG04	Letrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG05	Vorozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG06	Exemestan	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX	Andere Hormonantagonisten und verwandte Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX01	Abarelix	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX02	Degarelix	WHO Anatomical Therapeutic Chemical classification
0‑L	L03	Immunstimulanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	L03A	Zytokine und Immunmodulatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA	Koloniestimulierende Faktoren	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA02	Filgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA03	Molgramostim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA09	Sargramostim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA10	Lenograstim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA12	Ancestim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA13	Pegfilgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB	Interferone	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB01	Interferon-alfa, natürlich	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB02	Interferon-beta, natürlich	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB03	Interferon-gamma	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB04	Interferon-alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB05	Interferon-alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB06	Interferon-alfa-n1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB07	Interferon-beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB08	Interferon-beta-1b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB09	Interferon alfacon-1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB10	Peginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB11	Peginterferon alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB60	Peginterferon alfa-2b, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC	Interleukine	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC01	Aldesleukin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC02	Oprelvekin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX	Andere Zytokine und Immunmodulatoren	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX01	Lentinan	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX02	Roquinimex	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX03	BCG-Impfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX04	Pegademase	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX05	Pidotimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX07	Poly I:C	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX08	Poly ICLC	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX09	Thymopentin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX10	Immunocyanin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX11	Tasonermin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX12	Melanom-Impfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX13	Glatirameracetat	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX14	Histamin dihydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04	Immunsuppressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	L04A	Immunsuppressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA	Selektive Immunsuppressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA01	Ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA02	Muromonab-CD3	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA03	Antilymphocytäres Immunglobulin (Pferd)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA04	Antithymocytäres Immunglobulin (Kaninchen)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA05	Tacrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA06	Mycophenolsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA08	Daclizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA09	Basiliximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA10	Sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA11	Etanercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA12	Infliximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA13	Leflunomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA14	Anakinra	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA15	Alefacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA16	Afelimomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA17	Adalimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA18	Everolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA19	Gusperimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA21	Efalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA22	Abetimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA23	Natalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA24	Abatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA25	Eculizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA26	Belimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA28	Belatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB02	Infliximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC03	Anakinra	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC05	Ustekinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC07	Tocilizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD01	Ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD02	Tacrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX	Andere Immunsuppressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX01	Azathioprin	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX02	Thalidomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX03	Methotrexat	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX04	Lenalidomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX05	Pirfenidon	WHO Anatomical Therapeutic Chemical classification
0‑L	M	Muskel- und Skelettsystem	WHO Anatomical Therapeutic Chemical classification
0‑L	M01	Antiphlogistika und Antirheumatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M01A	Nichtsteroidale antiphlogistika und Antirheumatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA	Butylpyrazolidine	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA01	Phenylbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA02	Mofebutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA03	Oxyphenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA05	Clofezon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA06	Kebuzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB	Essigsäure-Derivate und verwandte Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB01	Indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB02	Sulindac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB03	Tolmetin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB04	Zomepirac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB05	Diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB06	Alclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB07	Bumadizon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB08	Etodolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB09	Lonazolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB10	Fentiazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB11	Acemetacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB12	Difenpiramid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB13	Oxametacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB14	Proglumetacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB15	Ketorolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB16	Aceclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB17	Bufexamac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB51	Indometacin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB55	Diclofenac, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC	Oxicame	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC01	Piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC02	Tenoxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC04	Droxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC05	Lornoxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC06	Meloxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE	Propionsäure-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE01	Ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE02	Naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE03	Ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE04	Fenoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE05	Fenbufen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE06	Benoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE07	Suprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE08	Pirprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE09	Flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE10	Indoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE11	Tiaprofensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE12	Oxaprozin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE13	Ibuproxam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE14	Dexibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE15	Flunoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE16	Alminoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE17	Dexketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE51	Ibuprofen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE52	Naproxen und Esomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE53	Ketoprofen, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG	Fenamate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG01	Mefenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG02	Tolfenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG03	Flufenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG04	Meclofenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH	Coxibe	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH01	Celecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH02	Rofecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH03	Valdecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH04	Parecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH05	Etoricoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH06	Lumiracoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX	Andere nichtsteroidale Antiphlogistika und Antirheumatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX01	Nabumeton	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX02	Nifluminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX04	Azapropazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX05	Glukosamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX07	Benzydamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX12	Glukosaminoglycanpolysulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX13	Proquazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX14	Orgotein	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX17	Nimesulid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX18	Feprazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX21	Diacerein	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX22	Morniflumat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX23	Tenidap	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX24	Oxaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX25	Chondroitinsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX68	Feprazon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01B	Antiphlogistika/Antirheumatika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA	Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA01	Phenylbutazon und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA02	Dipyrocetyl und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA03	Acetylsalicylsäure und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BX	Andere Antiphlogistika/Antirheumatika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	M01C	Spezifische Antirheumatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA	Chinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA03	Oxycinchophen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB	Gold-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB01	Natriumaurothiomalat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB02	Natrium aurothiosulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB03	Auranofin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB04	Aurothioglucose	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB05	Aurotioprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC	Penicillamin und ähnliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC01	Penicillamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC02	Bucillamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CX	Andere spezifische Antirheumatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M02	Topische Mittel gegen Gelenk- und Muskelschmerzen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02A	Topische Mittel gegen Gelenk- und Muskelschmerzen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA	Nichtsteroidale Antiphlogistika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA01	Phenylbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA02	Mofebutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA03	Clofezon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA04	Oxyphenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA05	Benzydamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA06	Etofenamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA07	Piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA08	Felbinac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA09	Bufexamac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA10	Ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA11	Bendazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA12	Naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA13	Ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA14	Fentiazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA15	Diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA16	Feprazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA17	Nifluminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA18	Meclofenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA19	Flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA21	Tolmetin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA22	Suxibuzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA23	Indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA24	Nifenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA25	Aceclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB	Capsicum-haltige Zubereitungen und ähnliche Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AC	Zubereitungen mit Salicylsäure-Derivaten	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX	Andere topische Mittel gegen Gelenk- und Muskelschmerzen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX02	Tolazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX03	Dimethylsulfoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX10	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	M03	Muskelrelaxanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	M03A	Muskelrelaxanzien, peripher wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA	Curare-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA01	Alcuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA02	Tubocurarin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA04	Dimethyltubocurarin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB	Cholin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB01	Suxamethonium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC	Andere quartäre Ammonium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC01	Pancuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC02	Gallamin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC03	Vecuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC04	Atracurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC05	Hexafluronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC06	Pipecuroniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC07	Doxacuriumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC08	Fazadiniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC09	Rocuroniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC10	Mivacuriumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC11	Cisatracurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX	Andere Muskelrelaxanzien, peripher wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX01	Botulinumtoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03B	Muskelrelaxanzien, zentral wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA	Carbaminsäureester	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA01	Phenprobamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA02	Carisoprodol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA03	Methocarbamol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA04	Styramat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA05	Febarbamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA51	Phenprobamat, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA52	Carisoprodol, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA53	Methocarbamol, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA71	Phenprobamat, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA72	Carisoprodol, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA73	Methocarbamol, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB	Oxazol-, Thiazin- und Triazin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB02	Chlormezanon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB03	Chlorzoxazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB52	Chlormezanon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB53	Chlorzoxazon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB72	Chlormezanon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB73	Chlorzoxazon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC	Ether, chemisch den Antihistaminika verwandt	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC01	Orphenadrin (citrat)	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC51	Orphenadrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX	Andere zentral wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX01	Baclofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX02	Tizanidin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX03	Pridinol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX04	Tolperison	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX05	Thiocolchicosid	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX06	Mephenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX07	Tetrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX08	Cyclobenzaprin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX30	Fenyramidol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03C	Muskelrelaxanzien, direkt wirkende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA	Dantrolen und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA01	Dantrolen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04	Gichtmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M04A	Gichtmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA	Urikostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA01	Allopurinol	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA02	Tisopurin	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA03	Febuxostat	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA51	Allopurinol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB	Urikosurika	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB01	Probenecid	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB02	Sulfinpyrazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB03	Benzbromaron	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB04	Isobromindion	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC	Gichtmittel ohne Effekt auf den Harnsäuremetabolismus	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC01	Colchicin	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC02	Cinchophen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX	Andere Gichtmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX01	Uratoxidase	WHO Anatomical Therapeutic Chemical classification
0‑L	M05	Mittel zur Behandlung von Knochenerkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	M05B	Mittel mit Einfluss auf die Knochenstruktur und die Mineralisation	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA	Bisphosphonate	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA01	Etidronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA02	Clodronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA03	Pamidronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA04	Alendronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA05	Tiludronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA06	Ibandronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA07	Risedronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA08	Zoledronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB	Bisphosphonate, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB01	Etidronsäure und Calcium, Sequenzialpräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB02	Risedronsäure und Calcium, Sequenzialpräparat	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB03	Alendronsäure und Colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC	Knochenmorphogene Proteine	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC01	Dibotermin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC02	Eptotermin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX	Andere Mittel mit Einfluß auf die Knochenstruktur und die Mineralisation	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX01	Ipriflavon	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX02	Aluminiumhydroxychlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX03	Strontium ranelat	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX04	Denosumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M09	Andere Mittel gegen Störungen des Muskel- und Skelettsystems	WHO Anatomical Therapeutic Chemical classification
0‑L	M09A	Andere Mittel gegen Störungen des Muskel- und Skelettsystems	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA	Chinin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA01	Hydrochinin	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA72	Chinin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB	Enzyme	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB01	Chymopapain	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB02	Kollagenase aus Clostridium histolyticum	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB52	Trypsin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX	Andere Mittel gegen Störungen des Muskel- und Skelettsystems	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX01	Hyaluronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N	Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	N01	Anästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01A	Allgemeinanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA	Ether	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA01	Diethylether	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA02	Vinylether	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB	Halogenierte Kohlenwasserstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB01	Halothan	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB02	Chloroform	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB03	Methoxyfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB04	Enfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB05	Trichlorethylen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB06	Isofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB07	Desfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB08	Sevofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF	Barbiturate, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF01	Methohexital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF02	Hexobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF03	Thiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG	Barbiturate in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG01	Narcobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH	Opioidanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH01	Fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH02	Alfentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH03	Sufentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH04	Phenoperidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH05	Anileridin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH06	Remifentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH51	Fentanyl, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX	Andere Allgemeinanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX01	Droperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX03	Ketamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX04	Propanidid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX05	Alfaxalon	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX07	Etomidate	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX10	Propofol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX11	Hydroxybuttersäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX13	Distickstoffmonoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX14	Esketamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX15	Xenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX63	Distickstoffmonoxid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01B	Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA	Ester der Aminobenzoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA01	Metabutethamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA02	Procain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA03	Tetracain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA04	Chloroprocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA05	Benzocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA52	Procain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB	Amide	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB01	Bupivacain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB02	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB03	Mepivacain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB04	Prilocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB05	Butanilicain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB06	Cinchocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB07	Etidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB08	Articain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB09	Ropivacain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB10	Levobupivacain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB51	Bupivacain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB52	Lidocain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB53	Mepivacain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB54	Prilocain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB57	Etidocain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB58	Articain, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC	Ester der Benzoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC01	Cocain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX	Andere Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX01	Ethylchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX02	Dyclonin	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX03	Phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX04	Capsaicin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02	Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02A	Opioide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA	Natürliche Opium-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA01	Morphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA02	Opium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA03	Hydromorphon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA04	Nicomorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA05	Oxycodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA08	Dihydrocodein	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA09	Diamorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA10	Papaveretum	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA51	Morphin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA55	Oxycodon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA58	Dihydrocodein, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA59	Codein, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA79	Codein, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB	Phenylpiperidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB01	Ketobemidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB02	Pethidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB03	Fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB52	Pethidin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB72	Pethidin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC	Diphenylpropylamin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC01	Dextromoramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC03	Piritramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC04	Dextropropoxyphen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC05	Bezitramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC52	Methadon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC54	Dextropropoxyphen, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC74	Dextropropoxyphen, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD	Benzomorphan-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD01	Pentazocin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD02	Phenazocin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE	Oripavin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE01	Buprenorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF	Morphinan-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF01	Butorphanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF02	Nalbufin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG	Opioide in Kombination mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG01	Morphin mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG02	Ketobemidon mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG03	Pethidin mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG04	Hydromorphon mit Spasmolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX	Andere Opioide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX01	Tilidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX02	Tramadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX03	Dezocin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX06	Tapentadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX52	Tramadol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02B	Andere Analgetika und Antipyretika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA	Salicylsäure und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA01	Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA02	Aloxiprin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA03	Cholinsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA04	Natriumsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA05	Salicylamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA06	Salsalat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA07	Ethenzamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA08	Morpholinsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA09	Dipyrocetyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA10	Benorilat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA11	Diflunisal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA12	Kaliumsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA14	Guacetisal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA15	Carbasalat calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA16	Imidazolsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA51	Acetylsalicylsäure, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA55	Salicylamid, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA57	Ethenzamid, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA59	Dipyrocetyl, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA65	Carbasalat calcium, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA71	Acetylsalicylsäure, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA75	Salicylamid, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA77	Ethenzamid, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA79	Dipyrocetyl, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB	Pyrazolone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB01	Phenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB02	Metamizol-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB03	Aminophenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB04	Propyphenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB05	Nifenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB51	Phenazon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB52	Metamizol-Natrium, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB53	Aminophenazon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB54	Propyphenazon, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB71	Phenazon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB72	Metamizol-Natrium, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB73	Aminophenazon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB74	Propyphenazon, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE	Anilide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE01	Paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE03	Phenacetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE04	Bucetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE05	Propacetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE51	Paracetamol, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE53	Phenacetin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE54	Bucetin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE71	Paracetamol, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE73	Phenacetin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE74	Bucetin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG	Andere Analgetika und Antipyretika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG02	Rimazolium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG03	Glafenin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG04	Floctafenin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG05	Viminol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG06	Nefopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG07	Flupirtin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG08	Ziconotid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG10	Nabiximols	WHO Anatomical Therapeutic Chemical classification
0‑L	N02C	Migränemittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA	Mutterkorn-Alkaloide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA01	Dihydroergotamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA02	Ergotamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA04	Methysergid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA07	Lisurid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA51	Dihydroergotamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA52	Ergotamin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA72	Ergotamin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB	Corticosteroid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB01	Flumedroxon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC	Selektive Serotonin-5HT1-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC01	Sumatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC02	Naratriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC03	Zolmitriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC04	Rizatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC05	Almotriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC06	Eletriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC07	Frovatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX	Andere Migränemittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX01	Pizotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX02	Clonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX03	Iprazochrom	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX05	Dimetotiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX06	Oxetoron	WHO Anatomical Therapeutic Chemical classification
0‑L	N03	Antiepileptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N03A	Antiepileptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA	Barbiturate und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA01	Methylphenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA02	Phenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA03	Primidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA04	Barbexaclon	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA30	Metharbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB	Hydantoin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB01	Ethotoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB02	Phenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB03	Amino(diphenylhydantoin)valeriansäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB04	Mephenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB05	Fosphenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB52	Phenytoin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB54	Mephenytoin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC	Oxazolidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC01	Paramethadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC02	Trimethadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC03	Ethadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD	Succinimid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD01	Ethosuximid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD02	Phensuximid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD03	Mesuximid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD51	Ethosuximid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE	Benzodiazepin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE01	Clonazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF	Carboxamid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF01	Carbamazepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF02	Oxcarbazepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF03	Rufinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF04	Eslicarbazepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG	Fettsäure-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG01	Valproinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG02	Valpromid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG03	Aminobuttersäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG04	Vigabatrin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG05	Progabid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG06	Tiagabin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX	Andere Antiepileptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX03	Sultiam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX07	Phenacemid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX09	Lamotrigin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX10	Felbamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX11	Topiramat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX12	Gabapentin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX13	Pheneturid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX14	Levetiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX15	Zonisamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX16	Pregabalin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX17	Stiripentol	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX18	Lacosamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX22	Perampanel	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX30	Beclamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04	Antiparkinsonmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N04A	Anticholinergika	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA	Tertiäre Amine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA01	Trihexyphenidyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA02	Biperiden	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA03	Metixen	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA04	Procyclidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA05	Profenamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA08	Dexetimid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA09	Phenglutarimid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA10	Mazaticol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA11	Bornaprin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA12	Tropatepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB	Ether, chemisch den Antihistaminika verwandt	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB01	Etanautin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB02	Orphenadrin (chlorid)	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC	Tropinether oder Tropin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC01	Benzatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC30	Etybenzatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04B	Dopaminerge Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA	Dopa und Dopa-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA01	Levodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA02	Levodopa und Decarboxylasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA03	Levodopa, Decarboxylasehemmer und COMT-Hemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA04	Melevodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA05	Melevodopa und Decarboxylasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA06	Etilevodopa und Decarboxylasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB	Adamantan-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB01	Amantadin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC	Dopamin-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC01	Bromocriptin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC02	Pergolid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC03	Dihydroergocryptinmesilat	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC04	Ropinirol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC05	Pramipexol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC06	Cabergolin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC07	Apomorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC08	Piribedil	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC09	Rotigotin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD	Monoaminoxidase-B-Hemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD01	Selegilin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD02	Rasagilin	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX	Andere dopaminerge Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX01	Tolcapon	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX02	Entacapon	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX03	Budipin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05	Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N05A	Antipsychotika	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA	Phenothiazine mit aliphatischer Seitenkette	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA01	Chlorpromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA02	Levomepromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA03	Promazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA04	Acepromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA05	Triflupromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA06	Cyamemazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA07	Chlorproethazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB	Phenothiazine mit Piperazinstruktur	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB01	Dixyrazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB02	Fluphenazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB03	Perphenazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB04	Prochlorperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB05	Thiopropazat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB06	Trifluoperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB07	Acetophenazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB08	Thioproperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB09	Butaperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB10	Perazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC	Phenothiazine mit Piperidinstruktur	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC01	Periciazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC02	Thioridazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC03	Mesoridazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC04	Pipotiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD	Butyrophenon-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD01	Haloperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD02	Trifluperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD03	Melperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD04	Moperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD05	Pipamperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD06	Bromperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD07	Benperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD08	Droperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD09	Fluanison	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE	Indol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE01	Oxypertin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE02	Molindon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE03	Sertindol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE04	Ziprasidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF	Thioxanthen-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF01	Flupentixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF02	Clopenthixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF03	Chlorprothixen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF04	Tiotixen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF05	Zuclopenthixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG	Diphenylbutylpiperidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG01	Fluspirilen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG02	Pimozid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG03	Penfluridol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH	Diazepine, Oxazepine und Thiazepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH01	Loxapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH02	Clozapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH03	Olanzapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH04	Quetiapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH05	Asenapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AK	Neuroleptika bei Spätdyskinesien	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AK01	Tetrabenazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL	Benzamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL01	Sulpirid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL02	Sultoprid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL03	Tiaprid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL04	Remoxiprid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL05	Amisulprid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL06	Veraliprid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL07	Levosulpirid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN	Lithium	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN01	Lithium	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX	Andere Antipsychotika	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX07	Prothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX08	Risperidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX09	Clotiapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX10	Mosapramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX11	Zotepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX12	Aripiprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX13	Paliperidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05B	Anxiolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA	Benzodiazepin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA01	Diazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA02	Chlordiazepoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA03	Medazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA04	Oxazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA05	Dikaliumclorazepat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA06	Lorazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA07	Adinazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA08	Bromazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA09	Clobazam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA10	Ketazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA11	Prazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA12	Alprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA13	Halazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA14	Pinazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA15	Camazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA16	Nordazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA17	Fludiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA18	Ethylloflazepat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA19	Etizolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA21	Clotiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA22	Cloxazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA23	Tofisopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA56	Lorazepam, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB	Diphenylmethan-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB01	Hydroxyzin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB02	Captodiam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB51	Hydroxyzin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC	Carbamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC01	Meprobamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC03	Emylcamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC04	Mebutamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC51	Meprobamat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD	Dibenzo-bicyclo-octadien-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD01	Benzoctamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE	Azaspirodecandion-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE01	Buspiron	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX	Andere Anxiolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX01	Mephenoxalon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX02	Gedocarnil	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX03	Etifoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05C	Hypnotika und Sedativa	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA	Barbiturate, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA01	Pentobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA02	Amobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA03	Butobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA04	Barbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA05	Aprobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA06	Secobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA07	Talbutal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA08	Vinylbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA09	Vinbarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA10	Cyclobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA11	Heptabarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA12	Reposal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA15	Methohexital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA16	Hexobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA19	Thiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA20	Etallobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA21	Allobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA22	Proxibarbal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB	Barbiturate, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB01	Kombinationen von Barbituraten	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB02	Barbiturate in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC	Aldehyde und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC01	Chloralhydrat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC02	Chloralodol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC03	Acetylglycinamidchloralhydrat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC04	Dichloralphenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC05	Paraldehyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD	Benzodiazepin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD01	Flurazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD02	Nitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD03	Flunitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD04	Estazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD05	Triazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD06	Lormetazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD07	Temazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD08	Midazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD09	Brotizolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD10	Quazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD11	Loprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD12	Doxefazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD13	Cinolazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE	Piperidindion-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE01	Glutethimid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE02	Methyprylon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE03	Pyrithyldion	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF	Benzodiazepin-verwandte Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF01	Zopiclon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF02	Zolpidem	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF03	Zaleplon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM	Andere Hypnotika und Sedativa	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM01	Methaqualon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM02	Clomethiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM03	Bromisoval	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM04	Carbromal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM05	Scopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM06	Propiomazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM07	Triclofos	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM08	Ethchlorvynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM09	Baldrian	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM10	Hexapropymate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM11	Bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM12	Apronal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM13	Valnoctamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM15	Methylpentynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM16	Niaprazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM17	Melatonin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM18	Dexmedetomidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX	Hypnotika und Sedativa in Kombination, exkl. Barbiturate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX01	Meprobamat, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX02	Methaqualon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX03	Methylpentynol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX04	Clomethiazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX05	Emepronium, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX06	Dipiperonylaminoethanol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N06	Psychoanaleptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06A	Antidepressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA	Nichtselektive Monoamin-Wiederaufnahmehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA01	Desipramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA02	Imipramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA03	Imipraminoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA04	Clomipramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA05	Opipramol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA06	Trimipramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA07	Lofepramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA08	Dibenzepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA09	Amitriptylin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA10	Nortriptylin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA11	Protriptylin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA12	Doxepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA13	Iprindol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA14	Melitracen	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA15	Butriptylin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA16	Dosulepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA17	Amoxapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA18	Dimetacrin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA19	Amineptin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA21	Maprotilin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA23	Quinupramin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB	Selektive Serotonin-Wiederaufnahmehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB02	Zimeldin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB03	Fluoxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB04	Citalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB05	Paroxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB06	Sertralin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB07	Alaproclat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB08	Fluvoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB09	Etoperidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB10	Escitalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AC	N06AC	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AD	N06AD	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AE	N06AE	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF	Monoaminoxidasehemmer, nichtselektiv	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF01	Isocarboxazid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF02	Nialamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF03	Phenelzin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF04	Tranylcypromin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF05	Iproniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF06	Iproclozid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG	Monoaminoxidase-A-Hemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG02	Moclobemid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG03	Toloxaton	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX	Andere Antidepressiva	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX01	Oxitriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX02	Tryptophan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX03	Mianserin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX04	Nomifensin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX05	Trazodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX06	Nefazodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX07	Minaprin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX08	Bifemelan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX09	Viloxazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX10	Oxaflozan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX11	Mirtazapin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX12	Bupropion	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX13	Medifoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX14	Tianeptin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX15	Pivagabin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX16	Venlafaxin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX17	Milnacipran	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX18	Reboxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX19	Gepiron	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX21	Duloxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX22	Agomelatin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX23	Desvenlafaxin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX25	Hyperici herba	WHO Anatomical Therapeutic Chemical classification
0‑L	N06B	Psychostimulanzien, Mittel für die ADHD und Nootropika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA	Zentral wirkende Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA01	Amfetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA02	Dexamfetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA03	Metamfetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA04	Methylphenidat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA05	Pemolin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA06	Fencamfamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA07	Modafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA08	Fenozolon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA09	Atomoxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA10	Fenetyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC	Xanthin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC01	Coffein	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC02	Propentofyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX	Andere Psychostimulanzien und Nootropika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX01	Meclofenoxat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX02	Pyritinol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX03	Piracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX04	Deanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX05	Fipexid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX06	Citicolin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX07	Oxiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX08	Pirisudanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX09	Linopirdin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX10	Nizofenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX11	Aniracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX12	Acetylcarnitin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX13	Idebenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX14	Prolintan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX15	Pipradrol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX16	Pramiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX17	Adrafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX18	Vinpocetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06C	Psycholeptikau und Psychoanaleptika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA	Antidepressiva in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA01	Amitriptylin und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA02	Melitracen und Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CB	Psychostimulanzien in Kombination mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	N06D	Antidementiva	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA	Cholinesterasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA01	Tacrin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA02	Donepezil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA03	Rivastigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA04	Galantamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX	Andere Antidementiva	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX01	Memantin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX02	Ginkgo biloba	WHO Anatomical Therapeutic Chemical classification
0‑L	N07	Andere Mittel für das Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	N07A	Parasympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA	Cholinesterasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA01	Neostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA02	Pyridostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA03	Distigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA30	Ambenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA51	Neostigmin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB	Cholinester	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB01	Carbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB02	Bethanechol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX	Andere Parasympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX01	Pilocarpin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX02	Cholinalfoscerat	WHO Anatomical Therapeutic Chemical classification
0‑L	N07B	Mittel zur Behandlung von Suchterkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA	Mittel zur Behandlung der Nikotinabhängigkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA01	Nicotin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA02	Bupropion	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA03	Vareniclin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB	Mittel zur Behandlung der Alkoholabhängigkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB01	Disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB02	Calcium carbimid	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB03	Acamprosat	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB04	Naltrexon	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC	Mittel zur Behandlung der Opiatabhängigkeit	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC01	Buprenorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC02	Methadon	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC03	Levacetylmethadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC04	Lofexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC51	Buprenorphin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07C	Antivertiginosa	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA	Antivertiginosa	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA01	Betahistin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA02	Cinnarizin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA03	Flunarizin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA04	Acetylleucin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA52	Cinnarizin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07X	Andere Mittel für das Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XA	Ganglioside und Gangliosid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX	Andere Mittel für das Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX01	Tirilazad	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX02	Riluzol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX03	Xaliproden	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX04	Hydroxybuttersäure	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX05	Amifampridin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX06	Tetrabenazin	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX07	Fampridin	WHO Anatomical Therapeutic Chemical classification
0‑L	P	Antiparasitäre Mittel, Insektizide und Repellenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	P01	Mittel gegen Protozoen-Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01A	Mittel gegen Amöben und andere Protozoen-Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA	Hydroxychinolin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA01	Broxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA02	Clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA04	Chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA05	Tilbroquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA52	Clioquinol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB	Nitroimidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB01	Metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB02	Tinidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB03	Ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB04	Azanidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB05	Propenidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB06	Nimorazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB07	Secnidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC	Dichloracetamid-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC01	Diloxanid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC02	Clefamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC03	Etofamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC04	Teclosan	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR	Arsen-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR01	Arsthinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR02	Difetarson	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR03	Glycobiarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR53	Glycobiarsol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX	Andere Mittel gegen Amöbiasis und andere Protozoen-Erkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX01	Chiniofon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX02	Emetin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX04	Phanquinon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX05	Mepacrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX06	Atovaquon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX07	Trimetrexat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX08	Tenonitrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX09	Dehydroemetin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX10	Fumagillin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX52	Emetin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01B	Malariamittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA	Aminochinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA01	Chloroquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA02	Hydroxychloroquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA03	Primaquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA06	Amodiaquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB	Biguanide	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB01	Proguanil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB02	Cycloguanilembonat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB51	Proguanil, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC	Methanolchinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC01	Chinin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC02	Mefloquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD	Diaminopyrimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD01	Pyrimethamin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD51	Pyrimethamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE	Artemisinin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE01	Artemisinin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE02	Artemether	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE03	Artesunat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE04	Artemotil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE05	Artenimol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE52	Artemether, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF01	Artemether und Lumefantrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF05	Artenimol und Piperaquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX	Andere Malariamittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX01	Halofantrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01C	Mittel gegen Leishmaniasis und Trypanosomiasis	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA	Nitroimidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA02	Benznidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB	Antimon-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB01	Megluminantimonat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB02	Natriumstibogluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC	Nitrofuran-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC01	Nifurtimox	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC02	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD	Arsen-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD01	Melarsoprol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD02	Acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX	Andere Mittel gegen Leishmaniasis und Trypanosomiasis	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX01	Pentamidinisethionat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX02	Suramin natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX03	Eflornithin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02	Anthelmintika	WHO Anatomical Therapeutic Chemical classification
0‑L	P02B	Trematodenmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA	Chinolin-Derivate und verwandte Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA01	Praziquantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA02	Oxamniquin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB	Organophosphat-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB01	Metrifonat	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX	Andere Trematodenmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX01	Bithionol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX02	Niridazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX03	Stibophen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX04	Triclabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02C	Nematodenmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA	Benzimidazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA01	Mebendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA02	Tiabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA03	Albendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA04	Ciclobendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA05	Flubendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA06	Fenbendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA51	Mebendazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB	Piperazin und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB01	Piperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB02	Diethylcarbamazin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC	Tetrahydropyrimidin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC01	Pyrantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC02	Oxantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE	Imidazothiazol-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE01	Levamisol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF	Avermektine	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF01	Ivermectin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX	Andere Nematodenmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX01	Pyrvinium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX02	Bephenium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02D	Bandwurmmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA	Salicylsäure-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA01	Niclosamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX	Andere Bandwurmmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX01	Desaspidin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX02	Dichlorophen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03	Mittel gegen Ektoparasiten, inkl. Antiscabiosa, Insektizide und Repellenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	P03A	Mittel gegen Ektoparasiten, inkl. Antiscabiosa	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA	Schwefel-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA01	Dixanthogen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA02	Kaliumpolysulfid	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA03	Mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA04	Disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA05	Thiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA54	Disulfiram, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB	Chlor-haltige Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB01	Clofenotan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB02	Lindan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB51	Clofenotan, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC	Pyrethrine, inkl. synthetische Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC01	Pyrethrum	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC02	Bioallethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC03	Phenothrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC04	Permethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC51	Pyrethrum, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC52	Bioallethrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC53	Phenothrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC54	Permethrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX	Andere Mittel gegen Ektoparasiten, inkl. Antiscabiosa	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX01	Benzylbenzoat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX02	Kupferoleat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX03	Malathion	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX04	Quassia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03B	Insektizide und Repellenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA	Pyrethrine	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA01	Cyfluthrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA02	Cypermethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA03	Decamethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA04	Tetramethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX	Andere Insektizide und Repellenzien	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX01	Diethyltoluamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX02	Dimethylphthalat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX03	Dibutylphthalat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX04	Dibutylsuccinat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX05	Dimethylcarbat	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX06	Etohexadiol	WHO Anatomical Therapeutic Chemical classification
0‑L	P52AF03	Oxantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P52AG09	Closantel Natrium Dihydrat für Tiere	WHO Anatomical Therapeutic Chemical classification
0‑L	P53AX25	Metaflumizon	WHO Anatomical Therapeutic Chemical classification
0‑L	Q	veterinär ATC	WHO Anatomical Therapeutic Chemical classification
0‑L	QA02BC01	Omeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03AB91	Synthetische Anticholinergika, quaternäre Ammoniumverbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03AX	andere Medikamente für funktionelle Darmstörung	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03AX13	Silikone	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03BB01	Butylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03DB04	Butylscopolamin und Analgetika	WHO Anatomical Therapeutic Chemical classification
0‑L	QA03FA01	Metoclopramid	WHO Anatomical Therapeutic Chemical classification
0‑L	QA04AD90	Maropitant	WHO Anatomical Therapeutic Chemical classification
0‑L	QA05AX90	Menbuton	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07AA06	Paromomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07AA10	Colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07AA51	Neomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07AA91	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07AA99	Antibiotika, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07BB	Bismuth Präparate	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07BC30	Kombinationen, andere intestinale Adsorbentien	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07CQ	Orale Elektrolyte und Kohlenhydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07FA01	Milchsäurebildner	WHO Anatomical Therapeutic Chemical classification
0‑L	QA07XA91	Zinkoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	QA08AB90	Mitratapid	WHO Anatomical Therapeutic Chemical classification
0‑L	QA08AB91	Dirlotapide	WHO Anatomical Therapeutic Chemical classification
0‑L	QA10AC03	Insulin (Schwein)	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11A	Multivitamine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11AB	Multivitamins, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11CC05	Colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11HA	andere Vitaminpräparate, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11JA	Kombinationen von Vitaminen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA11JC	Vitamine, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12	andere Mineralstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12AA03	Calciumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12AA07	Calciumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12AX	Calcium, Kombinationen mit Vitamin D und/oder anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12CE99	Selen-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12CX91	Butafosfan	WHO Anatomical Therapeutic Chemical classification
0‑L	QA12CX99	andere Mineralstoffe, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QA16Q	Präparate zur Prävention und/oder Behandlung von Acetonämie	WHO Anatomical Therapeutic Chemical classification
0‑L	QA16QA06	Monensin	WHO Anatomical Therapeutic Chemical classification
0‑L	QB02BA01	Phytomenadion	WHO Anatomical Therapeutic Chemical classification
0‑L	QB03AA02	Eisen(II)fumarat	WHO Anatomical Therapeutic Chemical classification
0‑L	QB03AC	Eisen dreiwertig, parenterale Präparate	WHO Anatomical Therapeutic Chemical classification
0‑L	QB03AC06	ferric oxide dextran complexes	WHO Anatomical Therapeutic Chemical classification
0‑L	QB03AC90	Eisen Dextran Komplex	WHO Anatomical Therapeutic Chemical classification
0‑L	QB03AC91	Gleptoferron	WHO Anatomical Therapeutic Chemical classification
0‑L	QB05AA90	Blutsubstitut und Plasmaprotein-Fraktion	WHO Anatomical Therapeutic Chemical classification
0‑L	QB05B	I.V.-Lösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	QB05BB	Lösungen für Elektrolytenhaushalt	WHO Anatomical Therapeutic Chemical classification
0‑L	QB05BB01	Elektrolyte	WHO Anatomical Therapeutic Chemical classification
0‑L	QB05XA30	Kombinationen von Elektrolyten	WHO Anatomical Therapeutic Chemical classification
0‑L	QC01CE90	Pimobendan	WHO Anatomical Therapeutic Chemical classification
0‑L	QC03AA56	Trichlormethiazide Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QC03CA01	Furosemid	WHO Anatomical Therapeutic Chemical classification
0‑L	QC03DA01	Spironolacton	WHO Anatomical Therapeutic Chemical classification
0‑L	QC04AD90	Propentofyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09AA02	Enalapril	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09AA05	Ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09AA07	Benazepril	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09AA16	Imidapril	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09BA07	Benazepril und Diuretika	WHO Anatomical Therapeutic Chemical classification
0‑L	QC09CA07	Telmisartan	WHO Anatomical Therapeutic Chemical classification
0‑L	QD	Dermatologika	WHO Anatomical Therapeutic Chemical classification
0‑L	QD01AA20	Antibiotika, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QD01AC90	Enilconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QD01AE20	Kombinationen, Antimykotika für topische Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	QD02AX	Andere Emollentia und Hautschutzmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	QD03AX90	Ketanserin	WHO Anatomical Therapeutic Chemical classification
0‑L	QD06A	Antibiotika für topische Anwendungen	WHO Anatomical Therapeutic Chemical classification
0‑L	QD06AA02	Chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	QD06AA03	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	QD07AC	Corticosteroide, stark wirksam (Gruppe III)	WHO Anatomical Therapeutic Chemical classification
0‑L	QD07AC16	Hydrocortisonaceponat	WHO Anatomical Therapeutic Chemical classification
0‑L	QD07AC90	Resocortolbutyrat	WHO Anatomical Therapeutic Chemical classification
0‑L	QD07CC01	Betamethason und Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QD07X	Kortikosteroide, sehr potent, andere Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08	Antiseptika und Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08A	Antiseptika und Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AC02	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AC52	Chlorhexidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AE02	Policresulen	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AG02	Povidon Jod	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AG03	Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	QD08AX	Antiseptika und Desinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	QG01AX	andere Antiinfektiva und Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	QG02AD01	Dinoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	QG02AD90	Cloprostenol	WHO Anatomical Therapeutic Chemical classification
0‑L	QG02AD91	Luprostiol	WHO Anatomical Therapeutic Chemical classification
0‑L	QG02CB01	Bromocriptin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG02CB03	Cabergolin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03AC06	Medroxyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03CA04	Estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03DA04	Progesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03DA90	Proligeston	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03DB06	Chlormadinon	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03DX90	Altrenogest	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03DX91	Delmadinone	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03GA01	Chorion-Gonadotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03GA03	Serum-Gonadotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03GA90	Follikel stimulierende Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03GA99	Gonadotropine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03GB	synthetische Eisprungstimulanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03XA91	Gonadotropin-Releasing-Faktor-Analogon, konjugiert	WHO Anatomical Therapeutic Chemical classification
0‑L	QG03XB90	Aglepriston	WHO Anatomical Therapeutic Chemical classification
0‑L	QG04BX91	Phenylpropanolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG04CX	Arzneimittel zur Behandlung der benignen Prostatahypertrophie	WHO Anatomical Therapeutic Chemical classification
0‑L	QG51A	Antiinfektiva und Antiseptika für die intrauterine Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	QG51AA	Antibakterielle Wirkstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	QG51AA02	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	QG51AA09	Formosulfathiazol (intrauterin)	WHO Anatomical Therapeutic Chemical classification
0‑L	QG51AA30	Antibiotika-Kombinationen zur intrauterinen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	QG52A	Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	QG52X	diverse Produkte für Zitzen und Euter	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01BB02	Oxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01BB03	Carbetocin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01CA	Gonadotropin-Releasing-Hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01CA01	Gonadorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01CA90	Buserelin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01CA92	Lecirelin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH01CA93	Deslorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	QH02AB01	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	QH02AB02	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	QH02AB56	Prednisolon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QH02CA01	Trilostan	WHO Anatomical Therapeutic Chemical classification
0‑L	QH03AA01	Levothyroxin-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	QH03BB01	Carbimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QH03BB02	Thiamazole	WHO Anatomical Therapeutic Chemical classification
0‑L	QI	Immunologika	WHO Anatomical Therapeutic Chemical classification
0‑L	QI 09AB07	Tocopherolacetat	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01	Immunologika für Aves	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA03	aviäre Infektiöse Bronchitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA06	aviäres infektiöse Bronchitis Virus + aviäres infekt.Bursitis (Gumboro) Virus + Newcastle Disease Virus/Paramyxo-Virus + aviäres Rhinotracheitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA13	Newcastle Disease Virus / Paramyxvirus + aviäre infektiöse Bronchitis Virus + aviäre Adenovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA17	aviäre Rhinotracheitis-Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA18	aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Adenovirus + aviäre Rhinotracheitisvirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA21	aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Rhinotracheitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AA23	aviäres Influenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB	Inaktivierter bakterieller Impfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB01	Salmonella	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB02	Pasteurella	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB05	Escherichia (Aves)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB07	Ornithobacterium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AB08	Clostridium (Aves)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD	aviärer lebend Virus-Impfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD01	avian rhinotracheitis virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD02	aviäre Enzephalomyelitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD03	Aviäres Herpesvirus (Mareksche Krankheit)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD04	Hühner Anaemie Virus (CIA)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD06	Newcastle Disease Virus / Paramyxovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD07	aviäres Infektiöse Bronchitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD08	Infektiöse Laryngotracheitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD09	avian infectious bursal disease virus (gumboro disease)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AD15	aviärs infektiöses Bursitis Virus (Gumboro) + aviäres Herpesvirus (Marek-Krankheit)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AE	Bakterieller Lebendimpfstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AE01	Salmonella	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AE03	Mycoplasma (Aves)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AE04	Escherichia (Aves)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01AN01	Kokzidien	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01BE	bakterieller Lebendimpfstoff für Ente	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01CA	inaktivierter viraler Impfstoff für Puten	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01CD01	Rhinotracheitisvirus, Puten-	WHO Anatomical Therapeutic Chemical classification
0‑L	QI01EA01	Paramyxovirus (Tauben)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02	Immunologika für Bovidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AA01	Bovinen Virusdiarrhoe	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AA02	Boviner respiratorische Syncytialvirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AA03	Bovine Rhinotracheitis Virus (IBR)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AA04	Maul- und Klauenseuchen Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AA08	Blauzungen Virus (Bovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AB	Inaktivierte bakterielle Impfstoffe (inkl. Mycoplasma, Toxoid und Chlamydien) - Bovidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AB01	Clostridium (Bovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AB04	Pasteurella (Bovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AD01	Bovines Rhinotracheitis Virus (IBR)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AD07	Bovines Respiratorisches Synzytialvirus + Bovines Parainfluenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AI01	lebend bovines Rotavirus + lebend bovines Coronavirus + inakt. Escherichia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AL01	bovines Rotavirus + bovines Coronavirus + Escherichia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AL04	Bovines Parainfluenza Virus + Bovines Respiratorisches Synzytialvirus + Pasteurella	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AM05	bovine Rotavirus Antiserum + bovine Coronavirus Antiserum + Escherichia Antiserum	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AP01	Trichophyton	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AR01	bovines Tuberculin PPD	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AR02	aviäres Tuberculin PPD	WHO Anatomical Therapeutic Chemical classification
0‑L	QI02AT01	Escherichia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI03	Immunologika für Capridae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI03AB	Inaktiviere bakterielle Impfung (inkl. Mycoplasma, Toxoid und Chlamydien) - Capridae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI03AC	Inaktivierte bakterielle Impfungen und Antisera	WHO Anatomical Therapeutic Chemical classification
0‑L	QI04	Immunologika für Ovidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI04AA02	Blauzungen Virus (Ovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI04AB01	Clostridium (Ovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI04AB03	Bacteroides (Ovidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05	Immunologika für Equidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AA	Virale Impfstoffe, inaktiviert	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AA01	equine Influenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AA04	equine Rhinopneumonitis-Virus + equine Influenzavirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AA05	Equines Rhinopneumonitis Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AA10	West Nile Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AB	inakt. bakterielle Impfung (inkl. Mycoplasma, Toxoid u. Chlamydien)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AB01	Streptococcen	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AB03	Clostridium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AD02	Equines Influenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AI01	Equines Influenza Virus + Clostridium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AL01	equine Influenza Virus + Clostridium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AM01	Clostridium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AQ	Trichophyton + Microsporum (Equidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI05AX	andere Immunologika (Equidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06	Immunologika für Felidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AA01	Feline Leukämievirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AA02	Feline Panleukopenie Virus / Parvovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AA04	felines Rhinotracheitis Virus + felines Calicivirus + felines Panleukopenie Virus / Parvovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AA06	Felines infektiöses Peritonitis (FIP) Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AA09	Panleukopenie + Calicivirus + Rhinotracheitis + Tollwut Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AD01	felines Panleukopenie Virus / Parvovirus (lebend viral)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AD03	felines Rhinotracheitisvirus und felines Calicivirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AD04	Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AE02	Bordetella (Felidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AF01	Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus + Chlamydia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH	Lebende und inaktivierte virale Impfungen (Felidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH04	lebend felines Panleukopenie Virus / Parovirus + inakt. Tollwut Virus + inakt. felines Rhinotracheitis Virus + inakt. felines Calicivirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH05	lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. Tollwut Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH07	lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. felines Leukaemie Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH08	lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AH09	lebend felines Rhinotracheitis Virus + lebend felines Panleukpenie Virus / Parvovirus + inakt. felines Calicivirus-Antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AJ	lebende und inaktivierte virale und bakterielle Impfstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AJ02	lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend Chlamydien	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AJ03	lebend felinesRhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend felines Panleukopenie Virus / Parvovirus + lebend Chlamydien	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AL01	felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + felines infektiöse Leukaemie Virus + Chlamydia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI06AL02	felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + inakt. Chlamydia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07	Immunologika für Canidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AA01	Parvovirose Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AA02	Rabiesvirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AA06	Canines Herpes-Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AB01	Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AB04	Borrelia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AD01	canines Parvovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AD02	canines Staupe Virus + canines Adenovirus + canines Parvovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AD03	canines Staupe Virus + canines Parovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AD04	canines Staupe Virus + canines Adenovirus + canines Parvovirus + canines Parainfluenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AD08	canine Parainfluenza-Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AE01	Bordetella	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AF	Lebende bakterielle und virale Impfungen (Canidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AI01	lebend canines Staupevirus + lebend canines Adenovirus + inakt. Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AI02	lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parainfluenza Virus + lebend canines Parvovirus + inakt. Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ	Lebende virale und inaktivierte virale und bakterielle Impfungen (Canidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ01	Staupe Virus (lebend) + Adenovirus (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ02	Staupevirus (lebend) + Adenovirus (inakt.) + Leptospirose (inakt.) Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ03	Staup Virus (lebend) + Adenovirus (inakt.) + Parvovirus (inakt.) + Leptospirose (inakt.) Viren	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ04	Staupe Virus (lebend) + Adenovirus (inakt.) + Parvovirose (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ05	lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parvovirus + inakt. Tollwut Virus + inakt. Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ06	lebend canines Staupevirus + lebend canines Adenovirus + lebend Parainfluenzavirus + lebend canines Parvovirus + inakt. Tollwutvirus + inakt. Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AJ10	canine Staupe Virus (lebend) + canine Adenovirus (lebend) + Parainfluenza Virus (lebend) + canine Parvovirus (lebend) + canine Coronavirus (inakt.) + Leptospira (inakt.)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AL01	Tollwut Virus + Leptospira	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AL05	Bordetella + Parainfluenza Virus (Canidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07AO	Inaktivierte Impfungen gegen Parasiten	WHO Anatomical Therapeutic Chemical classification
0‑L	QI07BD	lebend viraler Impfstoff (Fuchs)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI08	Immunologika für Leporidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI08AA01	Haemorrhagie-Virus (Kaninchen)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI08AD	viraler Lebendimpfstoff (Leporidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI08AD02	Myxomatose Virus (Leporidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09	Immunologika für Suidae	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AA02	porcines Parvovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AA03	Porcine Influenza Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AA05	Schweine-reproduktive und respiratorische Syndrom (PRRS)-Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AA06	Europäisches Schweinepestvirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AA07	Porcines Circovirus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB02	Escherichia (Suidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB03	Erysipelothrix	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB04	Bordetella + Pasteurella (Suidae)	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB07	Actinobacillus/Haemophilus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB08	Escherichia + Clostridium	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB13	Mycoplasma	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AB17	Mykoplasmen + Haemophilus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AD01	Aujeszkyʹscher Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AD03	PRRS-Virus	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AE04	Lawsonia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI09AL01	porcines Parvovirus + Erysipelothrix	WHO Anatomical Therapeutic Chemical classification
0‑L	QI10	Immunologika für Pisces	WHO Anatomical Therapeutic Chemical classification
0‑L	QI10AB01	Aeromonas	WHO Anatomical Therapeutic Chemical classification
0‑L	QI10BB03	Yersinia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI11	Immunologika für Rodentia	WHO Anatomical Therapeutic Chemical classification
0‑L	QI20	Andere Immunologika (Bienen, Frettchen, Nerz,...)	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA02	Doxycyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA03	Chlortetrazyklin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA06	Oxytetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA09	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA53	Chlortetracyclin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01AA56	oxytetracycline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01BA01	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01BA02	Thiamphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01BA90	Florfenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01BA99	Amfenicol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CA	Penicilline mit erweitertem Spektrum	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CA01	Ampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CA04	Amoxicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CE02	Phenoxymethylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CE09	Procain-Penicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CE90	Penethamat Hydroiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01CR02	Amoxicillin und Enzyminhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01DB01	Cefalexin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01DD90	Ceftiofur	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01DD91	Cefovecin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01DE90	Cefquinom	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EQ03	Sulfadimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EW03	Sulfadimidin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EW10	Sulfadiazin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EW11	Sulfamethoxazol und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EW12	Sulfachlorpyridazin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01EW13	Sulfadoxin und Trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA02	Spiramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA90	Tylosin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA91	Tilmicosin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA92	Tylvalosin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA94	Tulathromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA95	Gamithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FA96	Tildipirosin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FF01	Clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01FF52	Lincomycin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01GA90	Dihydrostreptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01GB03	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01GB04	Kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01GB05	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01GB90	Apramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA90	Enrofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA92	Danofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA93	Marbofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA94	Difloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA95	Orbifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA96	Ibafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01MA97	Pardofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01RA01	Penicilline, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01RA02	Sulfonamide, Kombinationen mit anderen Antibiotika (exkl.Trimethoprim)	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01RA04	Spiramycin, Kombination mit anderen antibakteriellen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01RA91	Makrolide, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01XB01	Colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01XQ01	Tiamulin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01XQ02	Valnemulin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ01XX92	Tiamulin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ02AC02	Itraconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51CA51	Ampicillin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51CE09	Procaine-Benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51CF02	Cloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51CR50	Kombinationen von Penicillinen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DA32	Cefoperazon	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DA92	Cefquinom	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DB01	Cefalexin (intramammär)	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DB04	Cefazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DB90	Cefalonium	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DD12	Cefoperazone	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51DE90	Cefquinom	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51E	Sulfonamiden und Trimethoprim für intramammäre Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51FF90	Pirlimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RC	Antibiotika Kombinationen für intramammäre Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RC01	Antibiotika Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RC22	Benzylpenicillin, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RC23	Procain Benzylpenicillin, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RC26	Cloxacillin, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RD01	Cefalexin, Kombinationen mit anderen antibakteriellen Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RF03	Lincomycin, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RG01	Neomycin, Kombinationen mit anderen Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51RV01	Antibiotika und Kortikosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	QJ51XX01	Rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	QL01XE90	Protein-Kinase-Inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	QL01XE91	Toceranib	WHO Anatomical Therapeutic Chemical classification
0‑L	QL03AB	Interferone	WHO Anatomical Therapeutic Chemical classification
0‑L	QL03AX	Immunstimulanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	QL04AD01	Ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AA01	Phenylbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AA90	Suxibuzon	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AC06	Meloxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AE03	Ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AE90	Vedaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AE91	Carprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AE92	Tepoxalin	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AG02	Tolfenaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AG90	Flunixin	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AH90	Firocoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AH91	Robenacoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AH92	Mavacoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AH93	Cimicoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AX12	Glykosaminoglykan Polysulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01AX90	Pentosan Polysulfat Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	QM01BA01	Phenylbutazon und Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	QM02AC99	Zubereitungen mit Salicylsäure-Derivaten, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QM03BX90	Guaifenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	QM05BA05	Tiludronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	QM05BC01	Dibotermin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	QM09AX01	Hyaluronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01	Anaesthetika	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01AB06	Isofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01AB08	Sevofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01AC52	Methadon-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01AX03	Ketamin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01AX10	Propofol	WHO Anatomical Therapeutic Chemical classification
0‑L	QN01BA02	Procain	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02AB03	Fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02AC52	Methadon-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02AE01	Buprenorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02AF	Morphinderivate	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02AF01	Butorphanol	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02BA01	Acetylsalicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02BA04	Natriumsalicylat	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02BB02	Metamizol Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02BB52	Metamizol Natrium, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	QN02BE01	Paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	QN03AA02	Phenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	QN03AX90	Imepitoin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN04BC02	Pergolid	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05AA04	Acepromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05BA01	Diazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CB02	Barbiturate in Kombination mit anderen Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CM11	Bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CM18	Dexmedetomidine	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CM90	Detomidin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CM91	Medetomidin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN05CM92	Xylazin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN06AA04	Clomipramin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN06AB03	Fluoxetin	WHO Anatomical Therapeutic Chemical classification
0‑L	QN06BC01	Xanthin-Derivate, Coffein	WHO Anatomical Therapeutic Chemical classification
0‑L	QN51AA01	Pentobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	QNO5AD90	Azaperon	WHO Anatomical Therapeutic Chemical classification
0‑L	QP51AJ01	Toltrazuril	WHO Anatomical Therapeutic Chemical classification
0‑L	QP51AJ03	Diclazuril	WHO Anatomical Therapeutic Chemical classification
0‑L	QP51AX08	Halofuginon	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AA01	Praziquantel	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AA51	Praziquantel-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AA54	Epsiprantel, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC01	Triclabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC02	Oxfendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC05	Fenbantel	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC06	Netobimin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC08	Cambendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC09	Mebendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC11	Albendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC12	Flubendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC13	Fenbendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AC55	Febantel-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52ACO1	Triclabendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AE01	Levamisol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AE51	Levamisol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AF02	Pyrantel	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AG05	Rafoxanid	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AG09	Closantel	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AX09	Monepantel	WHO Anatomical Therapeutic Chemical classification
0‑L	QP52AX60	Emodepsid und Toltrazuril	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AC04	Permethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AC05	Flumethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AC11	Deltamethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AC54	Permethrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AC55	Flumethrin-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AD01	Amitraz	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AD51	Amitraz, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AE02	Propoxur	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AF01	Phoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AF08	Guaifenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX04	Crotamiton	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX15	Fipronil	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX17	Imidacloprid	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX22	Thymol	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX23	Pyriproxifen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX25	Metaflumizone	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX26	Pyriprole	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX27	Indoxacarb	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53AX65	Fipronil-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53BC01	Lufenuron	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53BC51	Lufenuron, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53BD01	Methopren	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53BX02	Nitenpyram	WHO Anatomical Therapeutic Chemical classification
0‑L	QP53BX03	Spinosad	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AA01	Ivermectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AA03	Doramectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AA04	Epinomectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AA05	Selamectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AA51	Ivermectin-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AB02	Moxidectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AB51	Milbemycin Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QP54AB52	Moxidectin-Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	QR03CC13	Clenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	QR03CC90	Clentbuterol Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	QR05CB01	Acetylcystein	WHO Anatomical Therapeutic Chemical classification
0‑L	QR05CB02	Bromhexin	WHO Anatomical Therapeutic Chemical classification
0‑L	QR05CB90	Dembrexin hydrochlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	QS01AA13	Fusidinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	QS01AA90	Cloxacillin (ophtalmologische Präparate)	WHO Anatomical Therapeutic Chemical classification
0‑L	QS01XA18	Ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	QS02CA	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	QS02CA01	Prednisolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	QS02CA03	Hydrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	QS02CA91	Mometasone und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	QS02QA03	Ivermectin	WHO Anatomical Therapeutic Chemical classification
0‑L	QV03AB90	Atipamezole	WHO Anatomical Therapeutic Chemical classification
0‑L	QV03AN01	Oxygen	WHO Anatomical Therapeutic Chemical classification
0‑L	QV03AX	Nalfurafine	WHO Anatomical Therapeutic Chemical classification
0‑L	QV06DE	Kombinationen aus Aminosäuren, Elektroylten, Glucose und Vitaminen	WHO Anatomical Therapeutic Chemical classification
0‑L	R	Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	R01	Rhinologika	WHO Anatomical Therapeutic Chemical classification
0‑L	R01A	Dekongestiva und andere Rhinologika zur topischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA	Sympathomimetika, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA02	Cyclopentamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA03	Ephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA04	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA05	Oxymetazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA06	Tetryzolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA07	Xylometazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA08	Naphazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA09	Tramazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA10	Metizolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA11	Tuaminoheptan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA12	Fenoxazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA13	Tymazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA14	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB	Sympathomimetika, Kombinationen exkl. Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB01	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB02	Naphazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB03	Tetryzolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB05	Ephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB06	Xylometazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB07	Oxymetazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB08	Tuaminoheptan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC	Antiallergika, exkl. Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC01	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC02	Levocabastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC03	Azelastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC04	Antazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC05	Spagluminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC06	Thonzylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC07	Nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC08	Olopatadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC51	Cromoglicinsäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD	Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD01	Beclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD02	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD03	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD04	Flunisolid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD05	Budesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD06	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD07	Tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD08	Fluticason	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD09	Mometason	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD11	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD12	Fluticasonfuroat	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD52	Prednisolon, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD53	Dexamethason, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD57	Tixocortol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD58	Fluticason, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD60	Hydrocortison, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX	Andere Rhinologika	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX01	Calciumhexaminthiocyanat	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX02	Retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX03	Ipratropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX05	Ritiometan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX06	Mupirocin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX07	Hexamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX08	Framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX10	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01B	Nasale Dekongestiva zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA	Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA01	Phenylpropanolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA02	Pseudoephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA03	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA51	Phenylpropanolamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA52	Pseudoephedrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA53	Phenylephrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R02	Hals- und Rachentherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	R02A	Hals- und Rachentherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA	Antiseptika	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA01	Ambazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA02	Dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA03	Dichlorbenzylalkohol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA05	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA06	Cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA09	Benzethonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA10	Myristylbenzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA11	Chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA12	Hexylresorcinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA13	Acriflaviniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA14	Oxychinolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA15	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA16	Benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA17	Cetrimonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA18	Hexamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA19	Phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA20	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB01	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB02	Tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB03	Fusafungin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB04	Bacitracin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB30	Gramicidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD	Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD01	Benzocain	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD02	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD03	Cocain	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD04	Dyclonin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX01	Flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03	Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03A	Inhalative Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA	Alpha- und Beta-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA01	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB	Nichtselektive Beta-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB02	Isoprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB03	Orciprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC	Selektive Beta-2-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC02	Salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC03	Terbutalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC04	Fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC05	Rimiterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC06	Hexoprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC07	Isoetarin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC08	Pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC09	Tretoquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC10	Carbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC11	Tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC12	Salmeterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC13	Formoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC14	Clenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC15	Reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC16	Procaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC17	Bitolterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AH	Kombinationen von Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK	Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK01	Epinephrin und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK02	Isoprenalin und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK03	Fenoterol und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK04	Salbutamol und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK05	Reproterol und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK06	Salmeterol und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK07	Formoterol und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03B	Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA	Glucocorticoide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA01	Beclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA02	Budesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA03	Flunisolid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA04	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA05	Fluticason	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA06	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA07	Mometason	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA08	Ciclesonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB	Anticholinergika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB01	Ipratropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB02	Oxitropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB03	Stechapfel-haltige Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB04	Tiotropiumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC	Antiallergika, exkl. Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC01	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC03	Nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX	Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX01	Fenspirid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03C	Sympathomimetika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA	Alpha- und Beta-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA02	Ephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB	Nichtselektive Beta-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB01	Isoprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB02	Methoxyphenamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB03	Orciprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB51	Isoprenalin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB53	Orciprenalin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC	Selektive Beta2-Adrenorezeptor-Agonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC02	Salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC03	Terbutalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC04	Fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC05	Hexoprenalin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC06	Isoetarin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC07	Pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC08	Procaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC09	Tretoquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC10	Carbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC11	Tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC12	Bambuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC13	Clenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC14	Reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC53	Terbutalin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CK	Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03D	Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA	Xanthine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA01	Diprophyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA02	Cholintheophyllinat	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA03	Proxyphyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA04	Theophyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA05	Aminophyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA06	Etamiphyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA07	Theobromin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA08	Bamifyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA09	Acefyllinpiperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA10	Bufyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA11	Doxofyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA20	Kombinationen von Xanthinen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA51	Diprophyllin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA54	Theophyllin, Kombinationen exkl. Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA55	Aminophyllin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA57	Theobromin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA74	Theophyllin, Kombinationen mit Psycholeptika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB	Xanthine und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB01	Diprophyllin und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB02	Cholintheophyllinat und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB03	Proxyphyllin und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB04	Theophyllin und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB05	Aminophyllin und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB06	Etamiphyllin und Sympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC	Leukotrienrezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC01	Zafirlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC02	Pranlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC03	Montelukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC04	Ibudilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX	Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX01	Amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX02	Eprozinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX03	Fenspirid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX05	Omalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX06	Seratrodast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX07	Roflumilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R05	Husten- und Erkältungspräparate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05C	Expektoranzien, exkl. Kombinationen mit Antitussiva	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA	Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA01	Tyloxapol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA02	Kaliumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA03	Guaifenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA04	Ipecacuanha	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA05	Eibischwurzel	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA06	Senega	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA07	Antimonpentasulfid	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA08	Kreosot	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA09	Guajacolsulfonat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA11	Levoverbenon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA12	Hederae helicis folium	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB	Mukolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB01	Acetylcystein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB02	Bromhexin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB03	Carbocistein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB04	Eprazinon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB05	Mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB06	Ambroxol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB07	Sobrerol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB08	Domiodol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB09	Letostein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB10	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB11	Stepronin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB12	Tiopronin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB13	Dornase alfa (Desoxyribonuclease)	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB14	Neltenexin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB15	Erdostein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CP01	Thymiankraut	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CP02	Efeublätter	WHO Anatomical Therapeutic Chemical classification
0‑L	R05D	Antitussiva, exkl. Kombinationen mit Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA	Opium-Alkaloide und Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA01	Ethylmorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA03	Hydrocodon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA04	Codein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA05	Opium-Alkaloide mit Morphin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA06	Normethadon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA07	Noscapin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA08	Pholcodin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA09	Dextromethorphan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA10	Thebacon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA11	Dimemorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA12	Acetyldihydrocodein	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB	Andere Antitussiva	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB01	Benzonatat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB02	Benproperin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB03	Clobutinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB04	Isoaminil	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB05	Pentoxyverin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB07	Oxolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB09	Oxeladin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB10	Clofedanol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB11	Pipazetat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB12	Bibenzoniumbromid	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB13	Butamirat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB14	Fedrilat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB15	Zipeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB16	Dibunat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB17	Droxypropin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB18	Prenoxdiazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB19	Dropropizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB20	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB21	Cloperastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB22	Meprotixol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB23	Piperidion	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB24	Tipepidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB25	Morclofon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB26	Nepinalon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB27	Levodropropizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB28	Dimethoxanat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05F	Antitussiva und Expektoranzien, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA	Opium-Derivate und Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA01	Opium-Derivate und Mukolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA02	Opium-Derivate und Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB	Andere Antitussiva und Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB01	Antitussiva und Mukolytika	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB02	Antitussiva und Expektoranzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R05X	Andere Kombinationspräparate gegen Erkältungskrankheiten	WHO Anatomical Therapeutic Chemical classification
0‑L	R06	Antihistaminika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R06A	Antihistaminika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA	Aminoalkylether	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA01	Bromazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA02	Diphenhydramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA04	Clemastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA06	Chlorphenoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA07	Diphenylpyralin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA08	Carbinoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA09	Doxylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA52	Diphenhydramin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA54	Clemastin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA56	Chlorphenoxamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA57	Diphenylpyralin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB	Substituierte Alkylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB01	Brompheniramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB02	Dexchlorpheniramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB03	Dimetinden	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB04	Chlorphenamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB05	Pheniramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB06	Dexbrompheniramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB07	Talastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB51	Brompheniramin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB52	Dexchlorpheniramin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB54	Chlorphenamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB56	Dexbrompheniramin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC	Substituierte Ethylendiamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC01	Mepyramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC02	Histapyrrodin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC03	Chloropyramin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC04	Tripelennamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC05	Methapyrilen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC06	Thonzylamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC52	Histapyrrodin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC53	Chloropyramin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD	Phenothiazin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD01	Alimemazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD02	Promethazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD03	Thiethylperazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD04	Methdilazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD05	Hydroxyethylpromethazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD06	Thiazinam	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD07	Mequitazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD08	Oxomemazin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD09	Isothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD52	Promethazin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD55	Hydroxyethylpromethazin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE	Piperazin-Derivate	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE01	Buclizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE03	Cyclizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE04	Chlorcyclizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE05	Meclozin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE06	Oxatomid	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE07	Cetirizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE09	Levocetirizin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE51	Buclizin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE53	Cyclizin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE55	Meclozin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AK	Kombinationen von Antihistaminika	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX	Andere Antihistaminika zur systemischen Anwendung	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX01	Bamipin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX02	Cyproheptadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX03	Thenalidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX04	Phenindamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX05	Antazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX07	Triprolidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX08	Pyrrobutamin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX09	Azatadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX11	Astemizol	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX12	Terfenadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX13	Loratadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX15	Mebhydrolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX16	Deptropin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX17	Ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX18	Acrivastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX19	Azelastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX21	Tritoqualin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX22	Ebastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX23	Pimethixen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX24	Epinastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX25	Mizolastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX26	Fexofenadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX27	Desloratadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX28	Rupatadin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX29	Bilastin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX53	Thenalidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX58	Pyrrobutamin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R07	Andere Mittel für den Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	R07A	Andere Mittel für den Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA	Surfactant-Präparate	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA01	Colfoscerilpalmitat	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA02	Natürliche Phospholipide	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB	Atemstimulanzien	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB01	Doxapram	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB02	Nikethamid	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB03	Pentetrazol	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB04	Etamivan	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB05	Bemegrid	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB06	Prethcamid	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB07	Almitrin	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB08	Dimeflin	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB09	Mepixanox	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB52	Nikethamid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB53	Pentetrazol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX	Andere Mittel für den Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX01	Stickoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	S	Sinnesorgane	WHO Anatomical Therapeutic Chemical classification
0‑L	S01	Ophthalmika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01A	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA	Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA01	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA02	Chlortetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA03	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA04	Oxytetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA05	Tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA07	Framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA09	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA10	Natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA11	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA12	Tobramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA13	Fusidinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA14	Benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA15	Dihydrostreptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA16	Rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA17	Erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA18	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA19	Ampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA20	Antibiotika in Kombination mit anderen Mitteln	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA21	Amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA22	Micronomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA23	Netilmicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA24	Kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA25	Azidamfenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA26	Azithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA27	Cefuroxim	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA30	Kombinationen von Antibiotika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB	Sulfonamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB01	Sulfamethizol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB02	Sulfafurazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB03	Sulfadicramid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB04	Sulfacetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB05	Sulfafenazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD	Antivirale Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD01	Idoxuridin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD02	Trifluridin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD03	Aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD05	Interferon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD06	Vidarabin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD07	Famciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD08	Fomivirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD09	Ganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE01	Ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX	Andere Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX01	Quecksilber-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX02	Silber-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX03	Zink-haltige Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX04	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX05	Bibrocathol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX06	Resorcin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX07	Natriumborat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX08	Hexamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX09	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX10	Natriumpropionat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX11	Ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX12	Norfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX13	Ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX14	Dibrompropamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX15	Propamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX16	Picloxydin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX17	Lomefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX18	Povidon-Iod	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX19	Levofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX21	Gatifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX22	Moxifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01B	Antiphlogistika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA	Corticosteroide, rein	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA01	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA02	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA03	Cortison	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA04	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA05	Triamcinolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA06	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA07	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA08	Medryson	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA09	Clobetason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA10	Alclometason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA11	Desonid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA12	Formocortal	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA13	Rimexolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA14	Loteprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA15	Fluocinolon acetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB	Corticosteroide und Mydriatika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB01	Hydrocortison und Mydriatika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB02	Prednisolon und Mydriatika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB03	Fluorometholon und Mydriatika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB04	Betamethason und Mydriatika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC	Nichtsteroidale Antiphlogistika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC01	Indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC02	Oxyphenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC03	Diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC04	Flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC05	Ketorolac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC06	Piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC07	Bendazac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC08	Salicylsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC09	Pranoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC10	Nepafenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC11	Bromfenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01C	Antiphlogistika und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA01	Dexamethason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA02	Prednisolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA03	Hydrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA04	Fluocortolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA05	Betamethason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA06	Fludrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA07	Fluorometholon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA08	Methylprednisolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA09	Chlorprednison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA10	Fluocinolonacetonid und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA11	Clobetason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB	Corticosteroide/Antiinfektiva/Mydriatika in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB01	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB02	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB03	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB04	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB05	Fluorometholon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC	Nichtsteroidale Antiphlogistika und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC01	Diclofenac und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01E	Glaukommittel und Miotika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA	Sympathomimetika in der Glaukomtherapie	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA01	Epinephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA02	Dipivefrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA03	Apraclonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA04	Clonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA05	Brimonidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA51	Epinephrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB	Parasympathomimetika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB01	Pilocarpin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB02	Carbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB03	Ecothiopat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB04	Demecarium	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB05	Physostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB06	Neostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB07	Fluostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB08	Aceclidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB09	Acetylcholin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB10	Paraoxon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB51	Pilocarpin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB58	Aceclidin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC	Carboanhydrasehemmer	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC01	Acetazolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC02	Diclofenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC03	Dorzolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC04	Brinzolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC05	Methazolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED	Beta-Adrenorezeptor-Antagonisten	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED01	Timolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED02	Betaxolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED03	Levobunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED04	Metipranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED05	Carteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED06	Befunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED51	Timolol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED52	Betaxolol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED54	Metipranolol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED55	Carteolol, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE	Prostaglandin-Analoga	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE01	Latanoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE02	Unoproston	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE03	Bimatoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE04	Travoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE05	Tafluprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX	Andere Glaukommittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX01	Guanethidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX02	Dapiprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01F	Mydriatika und Zykloplegika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA	Anticholinergika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA01	Atropin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA02	Scopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA03	Methylscopolamin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA04	Cyclopentolat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA05	Homatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA06	Tropicamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA56	Tropicamid, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB	Sympathomimetika, exkl. Glaukommittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB01	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB02	Ephedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB03	Ibopamin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01G	Dekongestiva und Antiallergika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA	Sympathomimetika als Dekongestiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA01	Naphazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA02	Tetryzolin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA03	Xylometazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA04	Oxymetazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA05	Phenylephrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA06	Oxedrin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA51	Naphazolin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA52	Tetryzolin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA53	Xylometazolin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA55	Phenylephrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA56	Oxedrin, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX	Andere Antiallergika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX01	Cromoglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX02	Levocabastin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX03	Spagluminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX04	Nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX05	Lodoxamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX06	Emedastin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX07	Azelastin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX08	Ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX09	Olopatadin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX10	Epinastin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX51	Cromoglicinsäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01H	Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA	Lokalanästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA01	Cocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA02	Oxybuprocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA03	Tetracain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA04	Proxymetacain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA05	Procain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA06	Cinchocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA07	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01J	Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA	Farbstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA01	Fluorescein	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA02	Bengalrosa-Natrium	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA51	Fluorescein, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JX	Andere ophthalmologische Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01K	Chirurgische Hilfsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA	Viskoelastische Substanzen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA01	Hyaluronsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA02	Hypromellose	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA51	Hyaluronsäure, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX	Andere chirurgische Hilfsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX01	Chymotrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01L	Mittel gegen vaskuläre Augenerkrankungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA	Antineovaskuläre Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA01	Verteporfin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA02	Anecortav	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA03	Pegaptanib	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA04	Ranibizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01X	Andere Ophthalmika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA	Andere Ophthalmika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA01	Guajazulen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA02	Retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA03	Natriumchlorid, hyperton	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA04	Kaliumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA05	Natriumedetat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA06	Ethylmorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA07	Alaun	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA08	Acetylcystein	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA09	Iodoheparinat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA10	Inosin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA11	Nandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA12	Dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA13	Alteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA14	Heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA15	Ascorbinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA20	Künstliche Tränen und andere indifferente Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	S02	Otologika	WHO Anatomical Therapeutic Chemical classification
0‑L	S02A	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA01	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA02	Nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA03	Borsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA04	Aluminiumacetattartrat	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA05	Clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA06	Hydrogenperoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA07	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA08	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA09	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA10	Essigsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA11	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA12	Rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA13	Miconazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA14	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA15	Ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA16	Ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA30	Antiinfektiva, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S02B	Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA	Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA01	Hydrocortison	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA03	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA06	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA07	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S02C	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA01	Prednisolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA02	Flumetason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA03	Hydrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA04	Triamcinolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA05	Fluocinolonacetonid und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA06	Dexamethason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA07	Fludrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S02D	Andere Otologika	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA	Analgetika und Anästhetika	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA01	Lidocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA02	Cocain	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA30	Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DC	Indifferente Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S03	Ophthalmologische und otologische Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	S03A	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA	Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA01	Neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA02	Tetracyclin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA03	Polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA04	Chlorhexidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA05	Hexamidin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA06	Gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA07	Ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA08	Chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA30	Antiinfektiva, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	S03B	Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA	Corticosteroide	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA01	Dexamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA02	Prednisolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA03	Betamethason	WHO Anatomical Therapeutic Chemical classification
0‑L	S03C	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA	Corticosteroide und Antiinfektiva in Kombination	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA01	Dexamethason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA02	Prednisolon und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA04	Hydrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA05	Fludrocortison und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA06	Betamethason und Antiinfektiva	WHO Anatomical Therapeutic Chemical classification
0‑L	S03D	Andere ophthalmologische und otologische Zubereitungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V	Varia	WHO Anatomical Therapeutic Chemical classification
0‑L	V01	Allergene	WHO Anatomical Therapeutic Chemical classification
0‑L	V01A	Allergene	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA	Allergen-Extrakte	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA01	Federn	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA02	Gräserpollen	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA03	Hausstaub	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA04	Schimmel- und Hefepilze	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA05	Baumpollen	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA07	Insekten	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA08	Nahrungsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA09	Textilien	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA10	Blüten	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA11	Tiere	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA20	Verschiedene	WHO Anatomical Therapeutic Chemical classification
0‑L	V02	Immunosupressive agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V02C	Immunosupressive agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V02CA	Selective immunosuppressive agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V03	Alle übrigen therapeutischen Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V03A	Alle übrigen therapeutischen Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AA	Drugs for treatment on chronic alcoholism	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB	Antidote	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB01	Ipecacuanha	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB02	Nalorphin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB03	Edetate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB04	Pralidoxim	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB05	Prednisolon und Promethazin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB06	Thiosulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB08	Natriumnitrit	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB09	Dimercaprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB13	Obidoxim	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB14	Protamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB15	Naloxon	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB16	Ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB17	Methylthioniniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB18	Kaliumpermanganat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB19	Physostigmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB20	Kupfersulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB21	Kaliumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB22	Amylnitrit	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB23	Acetylcystein	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB24	Digitalis-Antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB25	Flumazenil	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB26	Methionin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB27	4-Dimethylaminophenol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB29	Cholinesterase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB31	Eisen(III)hexacyanoferrat(II)	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB32	Glutathion	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB33	Hydroxocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB34	Fomepizol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB35	Sugammadex	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC	Eisen-Chelatbildner	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC01	Deferoxamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC02	Deferipron	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC03	Deferasirox	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE	Mittel zur Behandlung der Hyperkaliämie und Hyperphosphatämie	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE01	Polystyrolsulfonat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE02	Sevelamer	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE03	Lanthan(III)-carbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE04	Calciumacetat und Mangesiumcarbonat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF	Entgiftungsmittel für die Behandlung mit Zytostatika	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF01	Mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF02	Dexrazoxan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF03	Calciumfolinat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF04	Calciumlevofolinat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF05	Amifostin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF06	Natriumfolinat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF07	Rasburicase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF08	Palifermin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF09	Glucarpidase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG	Mittel zur Behandlung der Hyperkalzämie	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG01	Natriumcellulosephosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH	Mittel zur Behandlung der Hypoglykämie	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH01	Diazoxid	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AK	Gewebekleber	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AM	Mittel zur Embolisation	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN	Medizinische Gase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN01	Sauerstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN02	Kohlendioxid	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN03	Helium	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN04	Stickstoff	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN05	Medizinische Luft	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX	Andere therapeutische Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ	Nerven dämpfende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ01	Ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04	Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V04AX	Other contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V04B	Urin-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04C	Andere Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA	Diabetes-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA01	Tolbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA02	Glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB	Fettabsorptions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB01	Vitamin-A-Konzentrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC	Gallenfluss-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC01	Sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC02	Magnesiumsulfat	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC03	Sincalid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC04	Ceruletid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD	Hypophysenfunktions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD01	Metyrapon	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD03	Sermorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD04	Corticoliberin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD05	Somatorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE	Leberfunktions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE01	Galactose	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE02	Bromsulfalein	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF	Tuberkulose-Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF01	Tuberkulin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG	Magensäuresekretions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG01	Kationenaustauscherharze	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG02	Betazol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG03	Histaminphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG04	Pentagastrin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG05	Methylthioniniumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG30	Coffein und Natriumbenzoat	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH	Nierenfunktions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH01	Inulin und andere Polyfructosane	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH02	Indigokarmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH03	Phenolsulfonphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH04	Alsactid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH30	Aminohippursäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ	Schilddrüsenfunktions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ01	Thyrotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ02	Protirelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK	Pankreasfunktions-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK01	Sekretin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK02	Pankreozymin (Cholecystokinin)	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK03	Bentiromid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CL	Allergie-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM	Fertilitäts-Tests	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM01	Gonadorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX	Andere Diagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V04D	Diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V06	Allgemeine Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	V06A	Diätetika zur Behandlung der Adipositas	WHO Anatomical Therapeutic Chemical classification
0‑L	V06AA	Niedrigkalorische Diäten	WHO Anatomical Therapeutic Chemical classification
0‑L	V06B	Proteinzusatznahrung	WHO Anatomical Therapeutic Chemical classification
0‑L	V06C	Säuglingsnahrung	WHO Anatomical Therapeutic Chemical classification
0‑L	V06CA	Diätetika ohne Phenylalanin	WHO Anatomical Therapeutic Chemical classification
0‑L	V06D	Andere Diätetika	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DA	Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DB	Fette/Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC	Kohlenhydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC01	Glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC02	Fructose	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DD	Aminosäuren, inkl. Kombination mit Polypeptiden	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DE	Aminosäuren/Kohlenhydrate/Mineralstoffe/Vitamine, Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DF	Milchersatzstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DX	Andere Diätetika-Kombinationen	WHO Anatomical Therapeutic Chemical classification
0‑L	V07	Alle übrigen nichttherapeutischen Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07A	Alle übrigen nichttherapeutischen Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AA	Pflaster	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AB	Lösungs- und Verdünnungsmittel, inkl. Spüllösungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AB01	Wasser	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AB02	Physiologische Kochsalzlösung	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AC	Bluttransfusionen, Hilfsstoffe	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AD	Blut-Tests, Hilfsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AN	Inkontinenz-Artikel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AR	Sensitivitäts-Tests, Plättchen und Tabletten	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AS	Stoma-Artikel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AT	Kosmetika	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AV	Technische Desinfektionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AX	Waschsubstanzen etc.	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AY	Andere nichttherapeutische Hilfsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AZ	Chemikalien und Reagenzien zur Analyse	WHO Anatomical Therapeutic Chemical classification
0‑L	V08	Kontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08A	Röntgenkontrastmittel, Iod-haltig	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA	Wasserlösliche nephrotrope hochosmolare Röntgenkontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA01	Amidotrizoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA02	Metrizoesäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA03	Iodamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA04	Iotalaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA05	Ioxitalaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA06	Ioglicinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA07	Acetrizoinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA08	Iocarminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA09	Methiodal	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA10	Diodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB	Wasserlösliche nephrotrope niederosmolare Röntgenkontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB01	Metrizamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB02	Iohexol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB03	Ioxaglinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB04	Iopamidol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB05	Iopromid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB06	Iotrolan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB07	Ioversol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB08	Iopentol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB09	Iodixanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB10	Iomeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB11	Iobitridol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB12	Ioxilan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC	Wasserlösliche hepatotrope Röntgenkontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC01	Iodoxaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC02	Iotroxinsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC03	Ioglycaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC04	Adipiodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC05	Iobenzaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC06	Iopansäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC07	Iocetaminsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC08	Natriumiopodat	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC09	Tyropansäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC10	Calciumiopodat	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD	Wasserunlösliche Röntgenkontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD01	Ethylester iodierter Fettsäuren	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD02	Iopydol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD03	Propyliodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD04	Iofendylat	WHO Anatomical Therapeutic Chemical classification
0‑L	V08B	Röntgenkontrastmittel, nicht Iod-haltig	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA	Bariumsulfat-haltige Röntgenkontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA01	Bariumsulfat mit Suspensionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA02	Bariumsulfat ohne Suspensionsmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08C	Kontrastmittel für die Magnetresonanztomographie	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA	Paramagnetische Kontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA01	Gadopentetsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA02	Gadotersäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA03	Gadodiamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA04	Gadoteridol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA05	Mangafodipir	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA06	Gadoversetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA07	Ammoniumeisen(III)citrat	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA08	Gadobensäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA09	Gadobutrol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA10	Gadoxetsäure	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA11	Gadofosveset	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB	Superparamagnetische Kontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB01	Ferumoxsil	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB02	Ferristen	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB03	Eisenoxid, Nanopartikel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX	Andere Kontrastmittel für die Magnetresonanztomographie	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX01	Perflubron	WHO Anatomical Therapeutic Chemical classification
0‑L	V08D	Ultraschall-Kontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA	Ultraschall-Kontrastmittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA01	Humanalbumin-Mikrosphären	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA02	Galactose-Mikropartikel	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA03	Perflenapent	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA04	Phospholipid-Mikrosphären	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA05	Schwefelhexafluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09	Radiodiagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V09A	Zentrales Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA01	[99mTc]Technetium-Exametazim	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA02	[99mTc]Technetiumbicisat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB	[123I]Iod-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB01	[123I]Iod-Iofetamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB02	[123I]Iod-Ioloprid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB03	[123I]Iod-Ioflupan	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX	Andere Radiodiagnostika für das zentrale Nervensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX01	[111In]Indiumpentetat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09B	Skelett	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA01	[99mTc]Technetiumoxidronat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA02	[99mTc]Technetiummedronat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA03	[99mTc]Technetiumpyrophosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA04	[99mTc]Technetiumbutedronat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09C	Nierensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA01	[99mTc]Technetiumpentetat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA02	[99mTc]Technetium-Succimer	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA03	[99mTc]Technetiummertiatid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA04	[99mTc]Technetiumglucoheptonat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA05	[99mTc]Technetiumgluconat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX	Andere Radiodiagnostika für das Nierensystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX01	[123I]Natrium-Iodhippurat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX02	[131I]Natrium-Iodhippurat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX03	[125I]Natrium-Iodthalamat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX04	[51Cr]Chromedetat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09D	Leber- und Retikuloendothelialsystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA01	[99mTc]Technetium-Disofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA02	[99mTc]Technetium-Etifenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA03	[99mTc]Technetium-Lidofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA04	[99mTc]Technetium-Mebrofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA05	[99mTc]Technetium-Galtifenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB	[99mTc]Technetium, Partikel und Kolloide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB01	[99mTc]Technetium-Nanokolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB02	[99mTc]Technetium-Mikrokolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB03	[99mTc]Technetium-Millimikrosphären	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB04	[99mTc]Technetium-Zinn-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB05	[99mTc]Technetium-Schwefel-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB06	[99mTc]Technetium-Rheniumsulfid-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB07	[99mTc]Technetiumphytat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX	Andere Radiodiagnostika für das Leber- und Retikuloendothelialsystem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX01	[75Se]Selenium-tauroselcholinat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09E	Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA	[99mTc]Technetium, Inhalate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA01	[99mTc]Technetiumpentetat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA02	[99mTc]Technetium, Technegas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA03	[99mTc]Technetium-Nanokolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB	[99mTc]Technetium, Partikel zur Injektion	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB01	[99mTc]Technetium-Macrosalb	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB02	[99mTc]Technetium-Mikrosphären	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX	Andere Radiodiagnostika für den Respirationstrakt	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX01	[81mKr]Kryptongas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX02	[127Xe]Xenongas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX03	[133Xe]Xenongas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09F	Schilddrüse	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX	Verschiedene Radiodiagnostika für die Schilddrüse	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX01	[99mTc]Technetiumpertechnetat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX02	[123I]Natriumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX03	[131I]Natriumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09G	Kardiovaskuläres System	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA01	[99mTc]Technetiumsestamibi	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA02	[99mTc]Technetiumtetrofosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA03	[99mTc]Technetiumteboroxim	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA04	[99mTc]Technetium-Humanalbumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA05	[99mTc]Technetiumfurifosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA06	[99mTc]Technetium-Zinn-markierte Zellen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA07	[99mTc]Technetiumapcitid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB	[125I]Iod-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB01	[125I]Fibrinogen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB02	[125I]Iod-Humanalbumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX	Andere Radiodiagnostika für das kardiovaskuläre System	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX01	[201Tl]Thalliumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX02	[111In]Indiumimciromab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX03	[51Cr]Chromchromat-markierte Zellen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09H	ENtzündungs- und Infektionserkennung	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA01	[99mTc]Technetium-Humanimmunglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA02	[99mTc]Technetium-Exametazim-markierte Zellen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA03	[99mTc]Technetium-Antigranulozyten-Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA04	[99mTc]Technetium-Sulesomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB	[111In]Indium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB01	[111In]Indiumoxinat-markierte Zellen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB02	[111In]Indiumtropolonat-markierte Zellen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX	Andere Radiodiagnostika zur Erkennung von Entzündungen und Infektionen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX01	[67Ga]Galliumcitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	V09I	Tumorerkennung	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA	[99mTc]Technetium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA01	[99mTc]Technetium-Anticarcinoembryoantigen-Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA02	[99mTc]Technetium-Antimelanom-Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA03	[99mTc]Technetiumsuccimer, pentavalent	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA04	[99mTc]Technetiumvotumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA05	[99mTc]Technetiumdepreotid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA06	[99mTc]Technetiumarcitumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB	[111In]Indium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB01	[111In]Indiumpentetreotid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB02	[111In]Indium-Satumomab-pendetid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB03	[111In]Indium-Antiovariumkarzinom-Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB04	[111In]Indium-Capromab-Pendetid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX	Andere Radiodiagnostika zur Tumorerkennung	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX01	[123I]Iobenguan	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX02	[131I]Iobenguan	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX03	[125I]Iod-CC49-Monoklonaler Antikörper	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX04	[18F]Fludeoxyglucose	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX05	[18F]Fluorodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX06	[18F]Natriumfluorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX07	[18F]Fluormethylcholin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09X	Andere Radiodiagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA	[131I]Iod-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA01	[131I]Iodnorcholesterol	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA02	[131I]Iodcholesterol	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA03	[131I]Iod- Humanalbumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX	Verschiedene Radiodiagnostika	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX01	[57Co]Cobaltcyanocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX02	[58Co]Cobaltcyanocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX03	[75Se]Selennorcholesterol	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX04	[59Fe]Eisen(III)-citrat	WHO Anatomical Therapeutic Chemical classification
0‑L	V10	Radiotherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	V10A	Entzündungshemmende Mittel	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA	[90Y]Yttrium-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA01	[90Y]Yttriumcitrat-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA02	[90Y]Yttrium-Eisen(III)hydroxid-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA03	[90Y]Yttriumsilicat-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX	Andere entzündungshemmende Radiotherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX01	[32P]Chrom(III)phosphat-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX02	[153Sm]Samariumhydroxyapatit-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX03	[165Dy]Dysprosium-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX04	[169Er]Erbiumcitrat-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX05	[186Re]Rheniumsulfid-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX06	[198Au]Gold-Kolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10B	Schmerzlinderung (Knochenmetastasen)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX	Verschiedene Radiopharmaka zur Schmerzlinderung	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX01	[89Sr]Strontiumchlorid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX02	[153Sm]Samariumlexidronam	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX03	[186Re]Rheniumetidronat	WHO Anatomical Therapeutic Chemical classification
0‑L	V10X	Andere Radiotherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA	[131I]Iod-Verbindungen	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA01	[131I]Natriumiodid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA02	[131I]Iobenguan	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA53	Tositumomab/[131I]Iod-Tositumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX	Verschiedene Radiotherapeutika	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX01	[32P]Natriumphosphat	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX02	[90Y] Ibritumomab tiuxetan	WHO Anatomical Therapeutic Chemical classification
0‑L	V20	Wundverbände	WHO Anatomical Therapeutic Chemical classification

Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.

XML JSON CSV SQL SVS